Amedeo Smart

Free Medical Literature Service


 

Amedeo

Influenza

  Free Subscription

Articles published in
J Infect Dis
    August 2022
  1. MAO Z, Li X, Korsten K, Bont L, et al
    Economic Burden and Health-Related Quality of Life of Respiratory Syncytial Virus and Influenza Infection in European Community-Dwelling Older Adults.
    J Infect Dis. 2022;226.
    >> Share

    July 2022
  2. BRITTO C, Mohorianu I, Yeung T, Cheung E, et al
    Host respiratory transcriptome signature associated with poor outcome in children with influenza-Staphylococcus aureus pneumonia.
    J Infect Dis. 2022 Jul 28. pii: 6650994. doi: 10.1093.
    >> Share

  3. WAGNER AL, Sanchez N, Kubale J, Kuan G, et al
    Single dose vaccination among infants and toddlers provides modest protection against influenza illness which wanes after 5 months.
    J Infect Dis. 2022 Jul 7. pii: 6633354. doi: 10.1093.
    >> Share

    June 2022
  4. TEMPLE DS, Hegarty-Craver M, Furberg RD, Preble EA, et al
    Wearable sensor-based detection of influenza in presymptomatic and asymptomatic individuals.
    J Infect Dis. 2022 Jun 27. pii: 6618641. doi: 10.1093.
    >> Share

  5. ACOSTA-AMPUDIA Y, Monsalve DM, Rojas M, Rodriguez Y, et al
    Persistent Autoimmune Activation and Proinflammatory State in Post-Coronavirus Disease 2019 Syndrome.
    J Infect Dis. 2022;225:2155-2162.
    >> Share

  6. VEDHARA K, Ayling K, Jia R, Fairclough L, et al
    Relationship Between Anxiety, Depression, and Susceptibility to Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Proof of Concept.
    J Infect Dis. 2022;225:2137-2141.
    >> Share

  7. TURNBULL J, Jha RR, Ortori CA, Lunt E, et al
    Serum Levels of Proinflammatory Lipid Mediators and Specialized Proresolving Molecules Are Increased in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 and Correlate With Markers of the Adaptive Immune Response.
    J Infect Dis. 2022;225:2142-2154.
    >> Share

  8. CHANG YH, Kao CC, Fang JJ, Lee YH, et al
    Correspondence to Morbidity and Mortality Among Adults Experiencing Homelessness Hospitalized With Coronavirus Disease 2019.
    J Infect Dis. 2022;225:2235.
    >> Share

  9. DEVINCENZO J, Cass L, Murray A, Woodward K, et al
    Safety and Antiviral Effects of Nebulized PC786 in a Respiratory Syncytial Virus Challenge Study.
    J Infect Dis. 2022;225:2087-2096.
    >> Share

  10. NYAWANDA BO, Otieno NA, Otieno MO, Emukule GO, et al
    The Impact of Maternal Human Immunodeficiency Virus Infection on the Burden of Respiratory Syncytial Virus Among Pregnant Women and Their Infants, Western Kenya.
    J Infect Dis. 2022;225:2097-2105.
    >> Share

  11. LAURIE MT, Liu J, Sunshine S, Peng J, et al
    SARS-CoV-2 Variant Exposures Elicit Antibody Responses With Differential Cross-Neutralization of Established and Emerging Strains Including Delta and Omicron.
    J Infect Dis. 2022;225:1909-1914.
    >> Share

    May 2022
  12. HAYDEN FG, Lenk RP, Stonis L, Oldham-Creamer C, et al
    Favipiravir Treatment of Uncomplicated Influenza in Adults: Results of Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials.
    J Infect Dis. 2022 May 26. pii: 6568151. doi: 10.1093.
    >> Share

  13. MONDELLI MU
    Antibodies: A Double Leg Takedown Against COVID-19.
    J Infect Dis. 2022;225:1685-1687.
    >> Share

  14. PATI A, Nayak N, Sarangi S, Barik D, et al
    CCL5 rs2107538 Variant Is Associated With Protection Against SARS-CoV-2 Infection and Related Mortality: A Population-Based Study.
    J Infect Dis. 2022;225:1865-1866.
    >> Share

  15. PEREZ-GARCIA F, Martin-Vicente M, Bermejo-Martin JF, Resino S, et al
    Reply to Pati et al.
    J Infect Dis. 2022;225:1866-1868.
    >> Share

  16. HAN T, Park H, Jeong Y, Lee J, et al
    COVID-19 Cluster Linked to Aerosol Transmission of SARS-CoV-2 via Floor Drains.
    J Infect Dis. 2022;225:1554-1560.
    >> Share

  17. BAHL P, Doolan C, de Silva C, Chughtai AA, et al
    Airborne or Droplet Precautions for Health Workers Treating Coronavirus Disease 2019?
    J Infect Dis. 2022;225:1561-1568.
    >> Share

    April 2022
  18. OKUDA M, Sakai-Tagawa Y, Koga M, Koibuchi T, et al
    Immunological correlates of prevention of the onset of seasonal H3N2 influenza.
    J Infect Dis. 2022 Apr 27. pii: 6574940. doi: 10.1093.
    >> Share

  19. REYES J, Stiehl B, Delgado J, Kinzel M, et al
    Human Research Study of Particulate Propagation Distance From Human Respiratory Function.
    J Infect Dis. 2022;225:1321-1329.
    >> Share

  20. IVERSEN KK, Afzal S, Ahlstrom MG, Nordestgaard BG, et al
    Lung Function Decline in Relation to COVID-19 in the General Population: A Matched Cohort Study With Prepandemic Assessment of Lung Function.
    J Infect Dis. 2022;225:1308-1316.
    >> Share

  21. AULD SC
    Lung Function After Coronavirus Disease 2019: Some Answers, More Questions.
    J Infect Dis. 2022;225:1305-1307.
    >> Share

  22. CHANG YH, Liaw YP
    Correspondence to Maternal-Fetal Immunologic Response to SARS-CoV-2 Infection in a Symptomatic Vulnerable Population: A Prospective Cohort.
    J Infect Dis. 2022;225:1494.
    >> Share

  23. XIONG W, Tsang TK, Perera RAPM, Leung NHL, et al
    Biphasic waning of hemagglutination inhibition antibody titers after influenza vaccination in children.
    J Infect Dis. 2022 Apr 5. pii: 6563665. doi: 10.1093.
    >> Share

  24. LEMIEUX JE, Luban J
    Consulting the Oracle of SARS-CoV-2 Infection.
    J Infect Dis. 2022;225:1115-1117.
    >> Share

  25. NUSSENBLATT V, Roder AE, Das S, de Wit E, et al
    Yearlong COVID-19 Infection Reveals Within-Host Evolution of SARS-CoV-2 in a Patient With B-Cell Depletion.
    J Infect Dis. 2022;225:1118-1123.
    >> Share

  26. KOIVISTO K, Nieminen T, Mejias A, Capella Gonzalez C, et al
    Respiratory Syncytial Virus (RSV)-Specific Antibodies in Pregnant Women and Subsequent Risk of RSV Hospitalization in Young Infants.
    J Infect Dis. 2022;225:1189-1196.
    >> Share

  27. FERGIE J, Suh M, Jiang X, Fryzek JP, et al
    Respiratory Syncytial Virus and All-Cause Bronchiolitis Hospitalizations Among Preterm Infants Using the Pediatric Health Information System (PHIS).
    J Infect Dis. 2022;225:1197-1204.
    >> Share

    March 2022
  28. RIEKE GJ, van Bremen K, Bischoff J, To Vinh M, et al
    Induction of NK cell-mediated antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 after natural infection is more potent than after vaccination.
    J Infect Dis. 2022 Mar 22. pii: 6552258. doi: 10.1093.
    >> Share

  29. PEREZ-GARCIA F, Martin-Vicente M, Rojas-Garcia RL, Castilla-Garcia L, et al
    High SARS-CoV-2 Viral Load and Low CCL5 Expression Levels in the Upper Respiratory Tract Are Associated With COVID-19 Severity.
    J Infect Dis. 2022;225:977-982.
    >> Share

  30. LI Y, Wang X, Cong B, Deng S, et al
    Understanding the Potential Drivers for Respiratory Syncytial Virus Rebound During the Coronavirus Disease 2019 Pandemic.
    J Infect Dis. 2022;225:957-964.
    >> Share

  31. LYSKI ZL, Brunton AE, Strnad MI, Sullivan PE, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific Memory B Cells From Individuals With Diverse Disease Severities Recognize SARS-CoV-2 Variants of Concern.
    J Infect Dis. 2022;225:947-956.
    >> Share

  32. NGUYEN D, Xiao J, Simmonds P, Lamikanra A, et al
    Effects of Severe Acute Respiratory Syndrome Coronavirus 2 Strain Variation on Virus Neutralization Titers: Therapeutic Use of Convalescent Plasma.
    J Infect Dis. 2022;225:971-976.
    >> Share

  33. DIEZ JM, Romero C, Cruz M, Vandeberg P, et al
    Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Hyperimmune Immunoglobulin Demonstrates Potent Neutralization and Antibody-Dependent Cellular Cytotoxicity and Phagocytosis Through N and S Proteins.
    J Infect Dis. 2022;225:938-946.
    >> Share

  34. ROHRIG A, Eyal N
    The Ethics of Human Challenge Trials Using Emerging Severe Acute Respiratory Syndrome 2 Variants.
    J Infect Dis. 2022;225:934-937.
    >> Share

  35. CUNNINGHAM JL, Virhammar J, Ronnberg B, Dopico XC, et al
    Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in the Serum and Cerebrospinal Fluid of Patients With Coronavirus Disease 2019 and Neurological Symptoms.
    J Infect Dis. 2022;225:965-970.
    >> Share

  36. MCLAUGHLIN JM, Khan F, Schmitt HJ, Agosti Y, et al
    Respiratory Syncytial Virus-Associated Hospitalization Rates among US Infants: A Systematic Review and Meta-Analysis.
    J Infect Dis. 2022;225:1100-1111.
    >> Share

  37. DEBIASI RL
    Severe Acute Respiratory Syndrome-Coronavirus-2 Effects at the Maternal-Fetal Interface.
    J Infect Dis. 2022;225:745-747.
    >> Share

  38. SHOOK LL, Brigida S, Regan J, Flynn JP, et al
    SARS-CoV-2 Placentitis Associated With B.1.617.2 (Delta) Variant and Fetal Distress or Demise.
    J Infect Dis. 2022;225:754-758.
    >> Share

  39. REGAN AK, Arah OA, Fell DB, Sullivan SG, et al
    SARS-CoV-2 Infection During Pregnancy and Associated Perinatal Health Outcomes: A National US Cohort Study.
    J Infect Dis. 2022;225:759-767.
    >> Share

  40. WELCH JL, Xiang J, Chang Q, Houtman JCD, et al
    T-Cell Expression of Angiotensin-Converting Enzyme 2 and Binding of Severe Acute Respiratory Coronavirus 2.
    J Infect Dis. 2022;225:810-819.
    >> Share

  41. LARCADE R, DeShea L, Lang GA, Caballero MT, et al
    Maternal-Fetal Immunologic Response to SARS-CoV-2 Infection in a Symptomatic Vulnerable Population: A Prospective Cohort.
    J Infect Dis. 2022;225:800-809.
    >> Share

  42. HWANG H, Lim JS, Song SA, Achangwa C, et al
    Transmission Dynamics of the Delta Variant of SARS-CoV-2 Infections in South Korea.
    J Infect Dis. 2022;225:793-799.
    >> Share

  43. KOTWA JD, Jamal AJ, Mbareche H, Yip L, et al
    Surface and Air Contamination With Severe Acute Respiratory Syndrome Coronavirus 2 From Hospitalized Coronavirus Disease 2019 Patients in Toronto, Canada, March-May 2020.
    J Infect Dis. 2022;225:768-776.
    >> Share

  44. PULVIRENTI F, Milito C, Cinetto F, Fernandez Salinas A, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Combination Therapy in Patients With Coronavirus Disease 2019 and Primary Antibody Deficiency.
    J Infect Dis. 2022;225:820-824.
    >> Share

  45. DIAZ-DIAZ A, Bunsow E, Garcia-Maurino C, Moore-Clingenpeel M, et al
    Nasopharyngeal Codetection of Haemophilus influenzae and Streptococcus pneumoniae Shapes Respiratory Syncytial Virus Disease Outcomes in Children.
    J Infect Dis. 2022;225:912-923.
    >> Share

    February 2022
  46. MORITZKY SA, Richards KA, Glover MA, Krammer F, et al
    The negative effect of pre-existing immunity on influenza vaccine responses transcends the impact of vaccine formulation type and vaccination history.
    J Infect Dis. 2022 Feb 24. pii: 6535476. doi: 10.1093.
    >> Share

  47. ROACH M, Hiatt RA, Black S
    Commentary: Race, COVID-19 and Nursing Homes.
    J Infect Dis. 2022;225:555-556.
    >> Share

  48. LORCA-ORO C, Vila J, Pleguezuelos P, Vergara-Alert J, et al
    Rapid SARS-CoV-2 Inactivation in a Simulated Hospital Room Using a Mobile and Autonomous Robot Emitting Ultraviolet-C Light.
    J Infect Dis. 2022;225:587-592.
    >> Share

  49. MONTAGUE BT, Wipperman MF, Hooper AT, Hamon SC, et al
    Anti-SARS-CoV-2 IgA Identifies Asymptomatic Infection in First Responders.
    J Infect Dis. 2022;225:578-586.
    >> Share

  50. ELHARAKE JA, Shafiq M, McFadden SM, Malik AA, et al
    The Association of Coronavirus Disease 2019 Risk Perception, County Death Rates, and Voluntary Health Behaviors Among United States Adult Population.
    J Infect Dis. 2022;225:593-597.
    >> Share

  51. RYAN KA, Schewe KE, Crowe J, Fotheringham SA, et al
    Sequential Delivery of Live Attenuated Influenza Vaccine and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the Ferret Model Can Reduce SARS-CoV-2 Shedding and Does Not Result in Enhanced Lung Pathology.
    J Infect Dis. 2022;225:404-412.
    >> Share

  52. OCHOA V, Diaz FE, Ramirez E, Fentini MC, et al
    Infants Younger Than 6 Months Infected With SARS-CoV-2 Show the Highest Respiratory Viral Loads.
    J Infect Dis. 2022;225:392-395.
    >> Share

  53. LEBREIL AL, Greux V, Glenet M, Huguenin A, et al
    Surfaces and Air Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 Using High-Flow Nasal Oxygenation or Assisted Mechanical Ventilation in Intensive Care Unit Rooms of Patients With Coronavirus Disease 2019.
    J Infect Dis. 2022;225:385-391.
    >> Share

  54. KLEIN J, Brito AF, Trubin P, Lu P, et al
    Longitudinal Immune Profiling of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection in a Solid Organ Transplant Recipient.
    J Infect Dis. 2022;225:374-384.
    >> Share

  55. CHAMBERLAIN AT, Toomey KE, Bradley H, Hall EW, et al
    Cumulative Incidence of SARS-CoV-2 Infections Among Adults in Georgia, United States, August to December 2020.
    J Infect Dis. 2022;225:396-403.
    >> Share

  56. MALENFANT JH, Eslami M, Dao BL, Moore L, et al
    Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Among Skilled Nursing Facility Residents and Staff Members-Los Angeles County, August-September 2020.
    J Infect Dis. 2022;225:367-373.
    >> Share

    January 2022
  57. KRAYNYAK KA, Blackwood E, Agnes J, Tebas P, et al
    SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial.
    J Infect Dis. 2022 Jan 25. pii: 6515374. doi: 10.1093.
    >> Share

  58. PUING AG, Ho S, Frankel P, Tegtmeier B, et al
    Severe Acute Respiratory Syndrome Coronavirus 2-Specific Monoclonal Antibody for the Treatment of Mild to Moderate Coronavirus Disease 2019 in Cancer Patients: A Single-Center Experience.
    J Infect Dis. 2022;225:352-354.
    >> Share

  59. KASPERSEN KA, Hindhede L, Boldsen JK, Mikkelsen S, et al
    Estimation of SARS-CoV-2 Infection Fatality Rate by Age and Comorbidity Status Using Antibody Screening of Blood Donors During the COVID-19 Epidemic in Denmark.
    J Infect Dis. 2022;225:219-228.
    >> Share

  60. STAPLETON EM, Welch JL, Ubeda EA, Xiang J, et al
    Urban Particulate Matter Impairment of Airway Surface Liquid-Mediated Coronavirus Inactivation.
    J Infect Dis. 2022;225:214-218.
    >> Share

  61. MERTZ C, Glowinski R, Cohen SH, Mertz S, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 RNAemia and Clinical Outcomes in Children With Coronavirus Disease 2019.
    J Infect Dis. 2022;225:208-213.
    >> Share

  62. KOVACEVIC A, Eggo RM, Baguelin M, Domenech de Celles M, et al
    The Impact of Cocirculating Pathogens on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/Coronavirus Disease 2019 Surveillance: How Concurrent Epidemics May Introduce Bias and Decrease the Observed SARS-CoV-2 Percentage Positivity.
    J Infect Dis. 2022;225:199-207.
    >> Share

  63. BUDER F, Bauswein M, Magnus CL, Audebert F, et al
    Contribution of High Viral Loads, Detection of Viral Antigen and Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 Infectivity.
    J Infect Dis. 2022;225:190-198.
    >> Share

  64. SHRAGAI T, Smith-Jeffcoat SE, Koh M, Schechter MC, et al
    Epidemiologic, Immunologic, and Virus Characteristics in Patients With Paired Severe Acute Respiratory Syndrome Coronavirus 2 Serology and Reverse-Transcription Polymerase Chain Reaction Testing.
    J Infect Dis. 2022;225:229-237.
    >> Share

  65. GUAN M, Johannesen E, Tang CY, Hsu AL, et al
    Intrauterine fetal demise in the third trimester of pregnancy associated with mild infection with the SARS-CoV-2 Delta variant without protection from vaccination.
    J Infect Dis. 2022 Jan 13. pii: 6506263. doi: 10.1093.
    >> Share

  66. KRISTENSEN JH, Hasselbalch RB, Pries-Heje M, Nielsen PB, et al
    Effect of influenza vaccination on risk of COVID-19 - A prospective cohort study of 46,000 health care workers.
    J Infect Dis. 2022 Jan 5. pii: 6497955. doi: 10.1093.
    >> Share

  67. MEMEL ZN, Lee JJ, Foulkes AS, Chung RT, et al
    Association of Statins and 28-Day Mortality Rates in Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    J Infect Dis. 2022;225:19-29.
    >> Share

  68. PATEL EU, Bloch EM, Tobian AAR
    Severe Acute Respiratory Syndrome Coronavirus 2 Serosurveillance in Blood Donor Populations.
    J Infect Dis. 2022;225:1-4.
    >> Share

  69. FRANCIS RV, Billam H, Clarke M, Yates C, et al
    The Impact of Real-Time Whole-Genome Sequencing in Controlling Healthcare-Associated SARS-CoV-2 Outbreaks.
    J Infect Dis. 2022;225:10-18.
    >> Share

    December 2021
  70. LUCZKOWIAK J, Labiod N, Rivas G, Rolo M, et al
    Neutralizing response against SARS-CoV-2 variants 8 months after BNT162b2 vaccination in naive and COVID-19 convalescent individuals.
    J Infect Dis. 2021 Dec 28. pii: 6486499. doi: 10.1093.
    >> Share

  71. BRUXVOORT KJ, Ackerson B, Sy LS, Bhavsar A, et al
    Recombinant adjuvanted zoster vaccine and reduced risk of COVID-19 diagnosis and hospitalization in older adults.
    J Infect Dis. 2021 Dec 28. pii: 6486498. doi: 10.1093.
    >> Share

  72. ABARA WE, Gee J, Delorey M, Tun Y, et al
    Expected Rates of Select Adverse Events following Immunization for COVID-19 Vaccine Safety Monitoring.
    J Infect Dis. 2021 Dec 27. pii: 6484617. doi: 10.1093.
    >> Share

  73. LIU J, Huang B, Li G, Chang X, et al
    Immunogenicity and Safety of a Three-Dose Regimen of a SARS-CoV-2 Inactivated Vaccine in Adults: A Randomized, Double-blind, Placebo-controlled Phase 2 Trial.
    J Infect Dis. 2021 Dec 27. pii: 6484920. doi: 10.1093.
    >> Share

  74. KIM SS, Naioti EA, Halasa NB, Stewart LS, et al
    Vaccine Effectiveness against Influenza Hospitalization and Emergency Department Visits in Two A(H3N2) Dominant Influenza Seasons among Children <18 Years Old, New Vaccine Surveillance Network 2016-17 and 2017-18.
    J Infect Dis. 2021 Dec 24. pii: 6482612. doi: 10.1093.
    >> Share

  75. FALSEY AR, Walsh EE, Scott DA, Gurtman A, et al
    Phase 1/2 Randomized Study of the Immunogenicity, Safety and Tolerability of an RSV Prefusion F Vaccine in Adults With Concomitant Inactivated Influenza Vaccine.
    J Infect Dis. 2021 Dec 21. pii: 6472733. doi: 10.1093.
    >> Share

  76. WALSH EE, Falsey AR, Scott DA, Gurtman A, et al
    A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine.
    J Infect Dis. 2021 Dec 21. pii: 6472747. doi: 10.1093.
    >> Share

  77. LEWIS NM, Naioti EA, Self WH, Ginde AA, et al
    Effectiveness of mRNA vaccines in preventing COVID-19 hospitalization by age and burden of chronic medical conditions among immunocompetent US adults, March-August 2021.
    J Infect Dis. 2021 Dec 21. pii: 6472998. doi: 10.1093.
    >> Share

  78. PHIJFFER EWEM, Bont LJ
    Are we ready for maternal RSV vaccination?
    J Infect Dis. 2021 Dec 21. pii: 6472740. doi: 10.1093.
    >> Share

  79. FAHIM SM, Hossain MS, Sen S, Das S, et al
    Nutrition and Food Security in Bangladesh: Achievements, Challenges, and Impact of the COVID-19 Pandemic.
    J Infect Dis. 2021;224.
    >> Share

  80. VERBURGH ML, Boyd A, Wit FWNM, Schim van der Loeff MF, et al
    Similar risk of SARS-CoV-2 infection and similar nucleocapsid antibody levels in people with well-controlled HIV and a comparable cohort of people without HIV.
    J Infect Dis. 2021 Dec 20. pii: 6470931. doi: 10.1093.
    >> Share

  81. GERIC C, Saroufim M, Landsman D, Richard J, et al
    Impact of Covid-19 on Tuberculosis Prevention and Treatment in Canada: a multicentre analysis of 10,833 patients.
    J Infect Dis. 2021 Dec 17. pii: 6469005. doi: 10.1093.
    >> Share

  82. LU Z, Laing ED, Pena DaMata J, Pohida K, et al
    Durability of SARS-CoV-2-Specific T-Cell Responses at 12 Months Postinfection.
    J Infect Dis. 2021;224:2010-2019.
    >> Share

  83. SCHULZE J, Mache C, Balazs A, Frey D, et al
    Analysis of Severe Acute Respiratory Syndrome 2 Replication in Explant Cultures of the Human Upper Respiratory Tract Reveals Broad Tissue Tropism of Wild-Type and B.1.1.7 Variant Viruses.
    J Infect Dis. 2021;224:2020-2024.
    >> Share

  84. PATI A, Padhi S, Nayak TKS, Panda AK, et al
    Angiotensin-Converting Enzyme 2 Genetic Variants Are Associated With Coronavirus Disease 2019.
    J Infect Dis. 2021;224:2181-2183.
    >> Share

  85. WOODFORD J, Sagara I, Dicko A, Zeguime A, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Seroassay Performance and Optimization in a Population With High Background Reactivity in Mali.
    J Infect Dis. 2021;224:2001-2009.
    >> Share

  86. KORSTEN K, Adriaenssens N, Coenen S, Butler CC, et al
    World Health Organization Influenza-Like Illness Underestimates the Burden of Respiratory Syncytial Virus Infection in Community-Dwelling Older Adults.
    J Infect Dis. 2021 Dec 14. pii: 6460601. doi: 10.1093.
    >> Share

  87. BROCKMAN MA, Mwimanzi F, Lapointe HR, Sang Y, et al
    Reduced magnitude and durability of humoral immune responses to COVID-19 mRNA vaccines among older adults.
    J Infect Dis. 2021 Dec 9. pii: 6458430. doi: 10.1093.
    >> Share

  88. NARANBHAI V, Garcia-Beltran WF, Chang CC, Mairena CB, et al
    Comparative immunogenicity and effectiveness of mRNA-1273, BNT162b2 and Ad26.COV2.S COVID-19 vaccines.
    J Infect Dis. 2021 Dec 9. pii: 6458467. doi: 10.1093.
    >> Share

  89. SHOOK LL, Bordt EA, Meinsohn MC, Pepin D, et al
    Placental Expression of ACE2 and TMPRSS2 in Maternal Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Are Placental Defenses Mediated by Fetal Sex?
    J Infect Dis. 2021;224.
    >> Share

  90. ZHOU J, Choi S, Liu H, Zhang J, et al
    Is SARS-CoV-2 Infection a Risk Factor for Early Pregnancy Loss? ACE2 and TMPRSS2 Coexpression and Persistent Replicative Infection in Primitive Trophoblast.
    J Infect Dis. 2021;224.
    >> Share

  91. ROBERTS DJ, Bebell LM, Edlow AG
    Severe Acute Respiratory Syndrome Coronavirus 2 ACE2 and TMPRSS2 Receptor Protein Expression Patterns Throughout Gestation.
    J Infect Dis. 2021;224.
    >> Share

  92. HALFMANN P, Nakajima N, Sato Y, Takahashi K, et al
    SARS-CoV-2 Interference of Influenza Virus Replication in Syrian Hamsters.
    J Infect Dis. 2021 Dec 7. pii: 6454972. doi: 10.1093.
    >> Share

  93. KIM G, Kim DH, Oh H, Bae S, et al
    Germinal Center-Induced Immunity Is Correlated With Protection Against SARS-CoV-2 Reinfection But Not Lung Damage.
    J Infect Dis. 2021;224:1861-1872.
    >> Share

  94. BENDER JK, Meyer ED, Sandfort M, Matysiak-Klose D, et al
    Low Sensitivity of Rapid Antigen Tests to Detect Severe Acute Respiratory Syndrome Coronavirus 2 Infections Before and on the Day of Symptom Onset in Nursing Home Staff and Residents, Germany, January-March 2021.
    J Infect Dis. 2021;224:1987-1989.
    >> Share

  95. YONKER LM, Boucau J, Regan J, Choudhary MC, et al
    Virologic Features of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children.
    J Infect Dis. 2021;224:1821-1829.
    >> Share

  96. BOPPANA SB, Pinninti SG, Britt WJ
    Coronavirus Disease 2019 and Children.
    J Infect Dis. 2021;224:1807-1809.
    >> Share

  97. LAU CS, Aw TC
    Frequent Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Testing in a Disease-Free Population.
    J Infect Dis. 2021;224:1986-1987.
    >> Share

  98. BIGGERSTAFF BJ, Akinbami LJ, Hales C, Chan PA, et al
    Duration of Viral Nucleic Acid Shedding and Early Reinfection With Severe Respiratory Syndrome Coronavirus 2 in Healthcare Workers and First Responders.
    J Infect Dis. 2021;224:1873-1877.
    >> Share

  99. BOYAPATI A, Wipperman MF, Ehmann PJ, Hamon S, et al
    Baseline Severe Acute Respiratory Syndrome Viral Load Is Associated With Coronavirus Disease 2019 Severity and Clinical Outcomes: Post Hoc Analyses of a Phase 2/3 Trial.
    J Infect Dis. 2021;224:1830-1838.
    >> Share

  100. PARK S, Michelow IC, Choe YJ
    Shifting Patterns of Respiratory Virus Activity Following Social Distancing Measures for Coronavirus Disease 2019 in South Korea.
    J Infect Dis. 2021;224:1900-1906.
    >> Share

    November 2021
  101. GILBOA M, Mandelboim M, Indenbaum V, Lustig Y, et al
    Early Immunogenicity and safety of the third dose of BNT162b2 mRNA Covid-19 vaccine among adults older than 60 years; real world experience.
    J Infect Dis. 2021 Nov 29. pii: 6446235. doi: 10.1093.
    >> Share

  102. KIM JY, Lim SY, Park S, Kwon JS, et al
    Immune responses to the ChAdOx1 nCoV-19 and BNT162b2 vaccines and to natural COVID-19 infections over a three-month period.
    J Infect Dis. 2021 Nov 25. pii: 6440288. doi: 10.1093.
    >> Share

  103. KUMAR S, Ghosh RS, Iyer H, Ray A, et al
    Typhoid in India: An Age-old Problem With an Existing Solution.
    J Infect Dis. 2021;224.
    >> Share

  104. AMBROSINO D, Han HH, Hu B, Liang J, et al
    Immunogenicity of SCB-2019 Coronavirus Disease 2019 Vaccine Compared With 4 Approved Vaccines.
    J Infect Dis. 2021 Nov 19. pii: 6431853. doi: 10.1093.
    >> Share

  105. FULDA ES, Fitch KV, Overton ET, Zanni MV, et al
    COVID-19 Vaccination Rates in a Global HIV Cohort.
    J Infect Dis. 2021 Nov 18. pii: 6431673. doi: 10.1093.
    >> Share

  106. COLLIER AY, Yu J, Mcmahan K, Liu J, et al
    COVID-19 mRNA Vaccine Immunogenicity in Immunosuppressed Individuals.
    J Infect Dis. 2021 Nov 18. pii: 6430790. doi: 10.1093.
    >> Share

  107. LEWIS AM, Zhang X, Brestoff JR
    Coronavirus Disease 2019 Severity in Obese Patients May Be Linked to Viral Load and Immune Response.
    J Infect Dis. 2021;224:1449-1451.
    >> Share

  108. EPSI NJ, Richard SA, Laing ED, Fries AC, et al
    Clinical, Immunological, and Virological SARS-CoV-2 Phenotypes in Obese and Nonobese Military Health System Beneficiaries.
    J Infect Dis. 2021;224:1462-1472.
    >> Share

  109. PELLEAU S, Woudenberg T, Rosado J, Donnadieu F, et al
    Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection.
    J Infect Dis. 2021;224:1489-1499.
    >> Share

  110. ZHOU M, Yin Z, Xu J, Wang S, et al
    Inflammatory Profiles and Clinical Features of Coronavirus 2019 Survivors 3 Months After Discharge in Wuhan, China.
    J Infect Dis. 2021;224:1473-1488.
    >> Share

  111. QUEEN J, Karaba S, Albin J, Karaba A, et al
    The Time is Now: A Call for Renewed Support of Infectious Diseases Physician-Scientist Trainees in the Era of Coronavirus Disease 2019.
    J Infect Dis. 2021;224:1452-1454.
    >> Share

  112. BIERLE DM, Ganesh R, Tulledge-Scheitel S, Hanson SN, et al
    Monoclonal Antibody Treatment of Breakthrough COVID-19 in Fully Vaccinated Individuals with High-Risk Comorbidities.
    J Infect Dis. 2021 Nov 16. pii: 6429422. doi: 10.1093.
    >> Share

  113. JOHNSON S, Martinez CI, Tedjakusuma SN, Peinovich N, et al
    Oral vaccination protects against SARS-CoV-2 in a Syrian hamster challenge model.
    J Infect Dis. 2021 Nov 10. pii: 6425228. doi: 10.1093.
    >> Share

  114. FERREIRA VH, Marinelli T, Ierullo M, Ku T, et al
    SARS-CoV-2 infection induces greater T-cell responses compared to vaccination in solid organ transplant recipients.
    J Infect Dis. 2021 Nov 5. pii: 6406613. doi: 10.1093.
    >> Share

  115. SACIUK Y, Kertes J, Shamir Stein N, Ekka Zohar A, et al
    Effectiveness of a third dose of BNT162b2 mRNA vaccine.
    J Infect Dis. 2021 Nov 2. pii: 6415586. doi: 10.1093.
    >> Share

    October 2021
  116. HUKIC M, Avdihodzic H, Veledar E, Korkut E, et al
    Potential Effect of Previous Human Coronavirus NL63 Infection on the Rate of Infection and the Clinical Course of Coronavirus Disease 2019.
    J Infect Dis. 2021;224:1444-1445.
    >> Share

  117. STOSOR V, Angarone MP
    Not All Monoclonal Antibodies for Coronavirus Disease 2019 Are Created Equal.
    J Infect Dis. 2021;224:1275-1277.
    >> Share

  118. HORTON DB, Barrett ES, Roy J, Gennaro ML, et al
    Determinants and Dynamics of SARS-CoV-2 Infection in a Diverse Population: 6-Month Evaluation of a Prospective Cohort Study.
    J Infect Dis. 2021;224:1345-1356.
    >> Share

  119. YANG Y, Kuang L, Li L, Wu Y, et al
    Distinct Mitochondria-Mediated T-Cell Apoptosis Responses in Children and Adults With Coronavirus Disease 2019.
    J Infect Dis. 2021;224:1333-1344.
    >> Share

  120. SANTOS BRAVO M, Nicolas D, Berengua C, Fernandez M, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Normalized Viral Loads and Subgenomic RNA Detection as Tools for Improving Clinical Decision Making and Work Reincorporation.
    J Infect Dis. 2021;224:1325-1332.
    >> Share

  121. BJORKMAN KK, Saldi TK, Lasda E, Bauer LC, et al
    Higher Viral Load Drives Infrequent Severe Acute Respiratory Syndrome Coronavirus 2 Transmission Between Asymptomatic Residence Hall Roommates.
    J Infect Dis. 2021;224:1316-1324.
    >> Share

  122. LI K, Wohlford-Lenane C, Bartlett JA, McCray PB, et al
    Intersubject Variation in ACE2 Protein Expression in Human Airway Epithelia and Its Relationship to Severe Acute Respiratory Syndrome Coronavirus 2.
    J Infect Dis. 2021;224:1357-1361.
    >> Share

  123. GANESH R, Philpot LM, Bierle DM, Anderson RJ, et al
    Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019.
    J Infect Dis. 2021;224:1278-1286.
    >> Share

  124. SHRWANI K, Sharma R, Krishnan M, Jones T, et al
    Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.
    J Infect Dis. 2021;224:1305-1315.
    >> Share

  125. DE GIORGI V, West KA, Henning AN, Chen LN, et al
    Naturally Acquired SARS-CoV-2 Immunity Persists for Up to 11 Months Following Infection.
    J Infect Dis. 2021;224:1294-1304.
    >> Share

  126. DIMCHEFF DE, Valesano AL, Rumfelt KE, Fitzsimmons WJ, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Total and Subgenomic RNA Viral Load in Hospitalized Patients.
    J Infect Dis. 2021;224:1287-1293.
    >> Share

  127. OWUSU D, Pomeroy MA, Lewis NM, Wadhwa A, et al
    Persistent SARS-CoV-2 RNA Shedding Without Evidence of Infectiousness: A Cohort Study of Individuals With COVID-19.
    J Infect Dis. 2021;224:1362-1371.
    >> Share

  128. MEIJIDE MIGUEZ H, Ochando Gomez M, Montes Garcia I, Garcia Merino IM, et al
    Cellular and humoral response, six months after two doses of BNT162b2 mRNA Covid 19 vaccination, in residents and staff of nursing homes for the elderly.
    J Infect Dis. 2021 Oct 28. pii: 6413766. doi: 10.1093.
    >> Share

  129. WITHANAGE K, De Coster I, Cools N, Viviani S, et al
    Phase 1 randomized, placebo-controlled, dose-escalating study to evaluate OVX836, a nucleoprotein-based influenza vaccine: intramuscular results.
    J Infect Dis. 2021 Oct 15. pii: 6398205. doi: 10.1093.
    >> Share

  130. WIDERA M, Wilhelm A, Hoehl S, Pallas C, et al
    Limited Neutralization of Authentic Severe Acute Respiratory Syndrome Coronavirus 2 Variants Carrying E484K In Vitro.
    J Infect Dis. 2021;224:1109-1114.
    >> Share

  131. DO LAH, Tsedenbal N, von Mollendorf C, Mungun T, et al
    Exploring the Possible Cause of the Dramatic Increase in Measles Mortality During the 2015-2016 Mongolian Outbreak.
    J Infect Dis. 2021;224:1266-1268.
    >> Share

  132. LEMARIE B, Boussaid G, Gault E, Prigent H, et al
    Predictors of hospitalization and superinfection in viral respiratory tract infections between influenza and paramyxoviruses: the SUPERFLUOUS study.
    J Infect Dis. 2021 Oct 12. pii: 6390777. doi: 10.1093.
    >> Share

  133. PETERSON JT, Zareba AM, Fitz-Patrick D, Essink BJ, et al
    Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Co-Administered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine.
    J Infect Dis. 2021 Oct 12. pii: 6391485. doi: 10.1093.
    >> Share

  134. DODD RY, Notari EP, Brodsky JP, Foster GA, et al
    Patterns of antibody response to SARS-CoV-2 among 1.6 million blood donors: Impact of vaccination, United States December 2020 - June 2021.
    J Infect Dis. 2021 Oct 9. pii: 6385747. doi: 10.1093.
    >> Share

  135. LU Y, Jiao Y, Graham DJ, Wu Y, et al
    Risk factors for COVID-19 deaths among elderly nursing home Medicare beneficiaries in the pre-vaccine period.
    J Infect Dis. 2021 Oct 7. pii: 6383455. doi: 10.1093.
    >> Share

    September 2021
  136. BECKER T, Elbahesh H, Reperant LA, Rimmelzwaan GF, et al
    Influenza Vaccines: Successes and Continuing Challenges.
    J Infect Dis. 2021;224.
    >> Share

  137. PELUSO MJ, Lu S, Tang AF, Durstenfeld MS, et al
    Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    J Infect Dis. 2021 Sep 27. pii: 6376537. doi: 10.1093.
    >> Share

  138. QI Y, Shaman J, Pei S
    Quantifying the impact of COVID-19 non-pharmaceutical interventions on influenza transmission in the United States.
    J Infect Dis. 2021 Sep 22. pii: 6374002. doi: 10.1093.
    >> Share

  139. XIAO J, de Mesquita JB, Leung NHL, Adenaiye O, et al
    Viral RNA and infectious influenza virus on mobile phones of influenza patients in Hong Kong and the United States.
    J Infect Dis. 2021 Sep 17. pii: 6371826. doi: 10.1093.
    >> Share

  140. GORSE GJ, Rattigan SM, Kirpich A, Simberkoff MS, et al
    Influence of Pre-Season Antibodies against Influenza Virus on Risk of Influenza Infection among Health Care Personnel.
    J Infect Dis. 2021 Sep 17. pii: 6371937. doi: 10.1093.
    >> Share

  141. BEVERLAND A, Keogan M, Connell J, De Gascun C, et al
    Longitudinal Serological Analysis Following a National Seroprevalence Study to Investigate COVID-19 Infection in People Living in Ireland.
    J Infect Dis. 2021;224:1100-1101.
    >> Share

  142. TONG M, Zheng Q, Chen F, Zhu Y, et al
    Comment on: Cell Adhesion Molecules and Vascular Endothelial Growth Factor at the Systemic and Alveolar Level in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome.
    J Infect Dis. 2021;224:1103-1104.
    >> Share

  143. KRISTENSEN MK, Plovsing RR, Berg RMG, Krogh-Madsen R, et al
    Cell Adhesion Molecules and Vascular Endothelial Growth Factor at the Systemic and Alveolar Level in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome.
    J Infect Dis. 2021;224:1101-1103.
    >> Share

  144. CHOE PG, Kang CK, Kim KH, Yi J, et al
    Persistence of Neutralizing Antibody Response up to 1 Year After Asymptomatic or Symptomatic SARS-CoV-2 Infection.
    J Infect Dis. 2021;224:1097-1099.
    >> Share

  145. ERREN TC, Lewis P, Morfeld P
    Factoring in Coronavirus Disease 2019 Seasonality: Experiences From Germany.
    J Infect Dis. 2021;224:1096.
    >> Share

  146. HEATON PM
    Herd Immunity: The Journey Is as Important as the Destination.
    J Infect Dis. 2021;224:931-933.
    >> Share

  147. FERREIRA IATM, Kemp SA, Datir R, Saito A, et al
    SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion.
    J Infect Dis. 2021;224:989-994.
    >> Share

  148. SMITH RL, Gibson LL, Martinez PP, Ke R, et al
    Longitudinal Assessment of Diagnostic Test Performance Over the Course of Acute SARS-CoV-2 Infection.
    J Infect Dis. 2021;224:976-982.
    >> Share

  149. KOECKERLING D, Barker J
    Accelerating the Evolution of Severe Acute Respiratory Syndrome Coronavirus 2: A Risk of Combining Dexamethasone and Tocilizumab for Severe Coronavirus Disease 2019.
    J Infect Dis. 2021;224:934-937.
    >> Share

  150. CHO K, Keithly SC, Kurgansky KE, Madenci AL, et al
    Early Convalescent Plasma Therapy and Mortality Among US Veterans Hospitalized With Nonsevere COVID-19: An Observational Analysis Emulating a Target Trial.
    J Infect Dis. 2021;224:967-975.
    >> Share

  151. RYU S, Hwang Y, Ali ST, Kim DS, et al
    Decreased Use of Broad-Spectrum Antibiotics During the Coronavirus Disease 2019 Epidemic in South Korea.
    J Infect Dis. 2021;224:949-955.
    >> Share

  152. GRZELAK L, Velay A, Madec Y, Gallais F, et al
    Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2.
    J Infect Dis. 2021;224:983-988.
    >> Share

  153. SUNTARATTIWONG P, Mott JA, Mohanty S, Sinthuwattanawibool C, et al
    Feasibility and Performance of Self-Collected Nasal Swabs for Detection of Influenza Virus, Respiratory Syncytial Virus, and Human Metapneumovirus.
    J Infect Dis. 2021;224:831-838.
    >> Share

  154. HILL KJ, Dewar R, Templeton K
    A Multiregional Evaluation of Cycle Threshold Values in Severe Acute Respiratory Syndrome Coronavirus 2 VOC-20DEC-01 Variant.
    J Infect Dis. 2021;224:927-928.
    >> Share

  155. RAN S, Su K, Zhang S, Liu B, et al
    The Association Between Coronavirus Disease 2019 Infection and Blood Constituents: A Mendelian Randomization Analysis.
    J Infect Dis. 2021;224:922-924.
    >> Share

  156. KIM MH, Salloum S, Wang JY, Wong LP, et al
    Type I, II, and III Interferon Signatures Correspond to Coronavirus Disease 2019 Severity.
    J Infect Dis. 2021;224:777-782.
    >> Share

  157. NOH JY, Kwak JE, Yang JS, Hwang SY, et al
    Longitudinal Assessment of Antisevere Acute Respiratory Syndrome Coronavirus 2 Immune Responses for Six Months Based on the Clinical Severity of Coronavirus Disease 2019.
    J Infect Dis. 2021;224:754-763.
    >> Share

  158. PATI A, Padhi S, Panda D, Suvankar S, et al
    A CD14 Polymorphism (C-159T rs2569190) Is Associated With SARS-CoV-2 Infection and Mortality in the European Population.
    J Infect Dis. 2021;224:921-922.
    >> Share

  159. ABDELNABI R, Foo CS, De Jonghe S, Maes P, et al
    Molnupiravir Inhibits Replication of the Emerging SARS-CoV-2 Variants of Concern in a Hamster Infection Model.
    J Infect Dis. 2021;224:749-753.
    >> Share

  160. PEREZ-LAGO L, Martinez-Lozano H, Pajares Diaz JA, Diaz Gomez A, et al
    Proper Assignation of Reactivation in a COVID-19 Recurrence Initially Interpreted as a Reinfection.
    J Infect Dis. 2021;224:788-792.
    >> Share

  161. PICHLER D, Baumgartner M, Kimpel J, Rossler A, et al
    Marked Increase in Avidity of SARS-CoV-2 Antibodies 7-8 Months After Infection Is Not Diminished in Old Age.
    J Infect Dis. 2021;224:764-770.
    >> Share

  162. TSANG TK, Wu P, Lau EHY, Cowling BJ, et al
    Accounting for Imported Cases in Estimating the Time-Varying Reproductive Number of Coronavirus Disease 2019 in Hong Kong.
    J Infect Dis. 2021;224:783-787.
    >> Share

  163. RAZANI N, Malekinejad M, Rutherford GW
    Clarification Regarding "Outdoor Transmission of SARS-CoV-2 and Other Respiratory Viruses: A Systematic Review".
    J Infect Dis. 2021;224:925-926.
    >> Share

  164. KILLERBY ME, Ata Ur Rasheed M, Tamin A, Harcourt JL, et al
    Shedding of Culturable Virus, Seroconversion, and 6-Month Follow-up Antibody Responses in the First 14 Confirmed Cases of Coronavirus Disease 2019 in the United States.
    J Infect Dis. 2021;224:771-776.
    >> Share

  165. LANE STARR NM, Evans MD, Lee KE, Gern JE, et al
    Ensemble Analysis Identifies Nasal 15-Keto-PGE2 as a Predictor of Recovery in Experimental Rhinovirus Colds.
    J Infect Dis. 2021;224:839-849.
    >> Share

    August 2021
  166. GIURGEA LT, Cervantes-Medina A, Walters KA, Scherler K, et al
    Sex Differences in Influenza: The Challenge Study Experience.
    J Infect Dis. 2021 Aug 23. pii: 6356350. doi: 10.1093.
    >> Share

  167. LINNIK J, Syedbasha M, Kaltenbach HM, Vogt D, et al
    Association of host factors with antibody response to seasonal influenza vaccination in allogeneic hematopoietic stem cell transplant (HSCT) patients.
    J Infect Dis. 2021 Aug 20. pii: 6355382. doi: 10.1093.
    >> Share

  168. DE MIGUEL BUCKLEY R, Diaz-Menendez M, Garcia-Rodriguez J, Arribas JR, et al
    Seasonal coronavirus pneumonia after SARS-Cov-2 infection and vaccine: new frenemies?
    J Infect Dis. 2021 Aug 20. pii: 6355378. doi: 10.1093.
    >> Share

  169. NATHAN N, Prevost B, Lambert S, Schnuriger A, et al
    SARS-CoV-2 variant Delta infects all 6 siblings but spares Comirnaty (BNT162b2, BioNTech/Pfizer)-vaccinated parents.
    J Infect Dis. 2021 Aug 19. pii: 6354728. doi: 10.1093.
    >> Share

  170. YANG CY, Lee YY, Wei JC
    Interpreting prevention of COVID-19 and vaccines.
    J Infect Dis. 2021 Aug 18. pii: 6354219. doi: 10.1093.
    >> Share

  171. PEART AKINDELE N, Kouo T, Karaba AH, Gordon O, et al
    Distinct Cytokine and Chemokine Dysregulation in Hospitalized Children With Acute Coronavirus Disease 2019 and Multisystem Inflammatory Syndrome With Similar Levels of Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 Shedding.
    J Infect Dis. 2021;224:606-615.
    >> Share

  172. BARLEV-GROSS M, Weiss S, Paran N, Yahalom-Ronen Y, et al
    Sensitive Immunodetection of Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern 501Y.V2 and 501Y.V1.
    J Infect Dis. 2021;224:616-619.
    >> Share

  173. MAZZITELLI I, Bleichmar L, Luduena MG, Pisarevsky A, et al
    Immunoglobulin G Immune Complexes May Contribute to Neutrophil Activation in the Course of Severe Coronavirus Disease 2019.
    J Infect Dis. 2021;224:575-585.
    >> Share

  174. BANDOPADHYAY P, D'Rozario R, Lahiri A, Sarif J, et al
    Nature and Dimensions of Systemic Hyperinflammation and its Attenuation by Convalescent Plasma in Severe COVID-19.
    J Infect Dis. 2021;224:565-574.
    >> Share

  175. PADHI S, Sahu S, Pati A, Mohanty AK, et al
    Minor Allele of Intercellular Adhesion Molecule-1 Polymorphism (rs5498 1462A>G) Is Associated With SARS-CoV-2 Infection and Related Mortality.
    J Infect Dis. 2021;224:734-735.
    >> Share

  176. RATCLIFF J, Nguyen D, Fish M, Rynne J, et al
    Virological Characterization of Critically Ill Patients With COVID-19 in the United Kingdom: Interactions of Viral Load, Antibody Status, and B.1.1.7 Infection.
    J Infect Dis. 2021;224:595-605.
    >> Share

  177. YAO L, Wang GL, Shen Y, Wang ZY, et al
    Persistence of Antibody and Cellular Immune Responses in Coronavirus Disease 2019 Patients Over Nine Months After Infection.
    J Infect Dis. 2021;224:586-594.
    >> Share

  178. SOUTHWICK FS
    Improving the Definition of Coronavirus Disease 2019-Related Deaths.
    J Infect Dis. 2021;224:375-376.
    >> Share

  179. AVIV R, Weber A, Anzum T, Federbush M, et al
    Prolonged Coronavirus Disease 2019 in a Patient With Rheumatoid Arthritis on Rituximab Therapy.
    J Infect Dis. 2021;224:557-559.
    >> Share

  180. ALLAN-BLITZ LT, Klausner JD
    Reply: Seroprevalence of SARS-CoV-2 After the Largest Initial Epidemic Wave in the United States: Findings from New York City, May 13-July 21, 2020.
    J Infect Dis. 2021;224:556-557.
    >> Share

  181. HALL JA, Harris RJ, Emmett HE, Lowe B, et al
    On the Sensitivity and Specificity of Postmortem Upper Respiratory Tract Testing for SARS-CoV-2.
    J Infect Dis. 2021;224:389-394.
    >> Share

  182. MEISTER TL, Fortmann J, Todt D, Heinen N, et al
    Comparable Environmental Stability and Disinfection Profiles of the Currently Circulating SARS-CoV-2 Variants of Concern B.1.1.7 and B.1.351.
    J Infect Dis. 2021;224:420-424.
    >> Share

  183. ALKHARAAN H, Bayati S, Hellstrom C, Aleman S, et al
    Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys.
    J Infect Dis. 2021;224:407-414.
    >> Share

  184. BOUMAZA A, Gay L, Mezouar S, Bestion E, et al
    Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis.
    J Infect Dis. 2021;224:395-406.
    >> Share

    July 2021
  185. EIDEN J, Volckaert B, Rudenko O, Aitchison R, et al
    Single Replication M2SR Influenza Vaccine Induced Immune Responses Associated with Protection Against Human Challenge with Highly Drifted H3N2 Influenza Strain.
    J Infect Dis. 2021 Jul 29. pii: 6330582. doi: 10.1093.
    >> Share

  186. GIL RM, Freeman T, Mathew T, Kullar R, et al
    The LGBTQ+ communities and the COVID-19 pandemic: a call to break the cycle of structural barriers.
    J Infect Dis. 2021 Jul 29. pii: 6330600. doi: 10.1093.
    >> Share

  187. PARROTT JC, Maleki AN, Vassor VE, Osahan S, et al
    Prevalence of SARS-CoV-2 Antibodies in New York City Adults, June-October 2020: A Population-Based Survey.
    J Infect Dis. 2021;224:188-195.
    >> Share

  188. CASADO JL, Vizcarra P, Velasco H, Hammerle J, et al
    Progressive and Parallel Decline of Humoral and T-Cell Immunity in Convalescent Healthcare Workers with Asymptomatic or Mild-to-Moderate Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    J Infect Dis. 2021;224:241-245.
    >> Share

  189. PANDA AK, Pati A, Padhi S, Sahoo AK, et al
    Association of Granulin rs5848 (C>T) Polymorphism With Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Mortality Rate.
    J Infect Dis. 2021;224:366-367.
    >> Share

  190. BERNAL E, Gimeno L, Alcaraz MJ, Quadeer AA, et al
    Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated With the Severity of Coronavirus Disease 2019.
    J Infect Dis. 2021;224:229-240.
    >> Share

  191. JALKANEN P, Pasternack A, Maljanen S, Melen K, et al
    A Combination of N and S Antigens With IgA and IgG Measurement Strengthens the Accuracy of SARS-CoV-2 Serodiagnostics.
    J Infect Dis. 2021;224:218-228.
    >> Share

  192. VILLARINO E, Deng X, Kemper CA, Jorden MA, et al
    Introduction, Transmission Dynamics, and Fate of Early Severe Acute Respiratory Syndrome Coronavirus 2 Lineages in Santa Clara County, California.
    J Infect Dis. 2021;224:207-217.
    >> Share

  193. PATHELA P, Crawley A, Weiss D, Maldin B, et al
    Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Following the Largest Initial Epidemic Wave in the United States: Findings From New York City, 13 May to 21 July 2020.
    J Infect Dis. 2021;224:196-206.
    >> Share

  194. HALL MD, Anderson JM, Anderson A, Baker D, et al
    Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit.
    J Infect Dis. 2021;224.
    >> Share

  195. YEO KT, Yung CF, Khoo PC, Saffari SE, et al
    Effectiveness of Palivizumab Against Respiratory Syncytial Virus Hospitalization Among Preterm Infants in a Setting With Year-Round Circulation.
    J Infect Dis. 2021;224:279-287.
    >> Share

  196. BERBERS G, Mollema L, van der Klis F, den Hartog G, et al
    Antibody Responses to Respiratory Syncytial Virus: A Cross-Sectional Serosurveillance Study in the Dutch Population Focusing on Infants Younger Than 2 Years.
    J Infect Dis. 2021;224:269-278.
    >> Share

  197. SYED F, Li W, Relich RF, Russell PM, et al
    Excessive Matrix Metalloproteinase-1 and Hyperactivation of Endothelial Cells Occurred in COVID-19 Patients and Were Associated With the Severity of COVID-19.
    J Infect Dis. 2021;224:60-69.
    >> Share

  198. DA SILVA ANTUNES R, Pallikkuth S, Williams E, Dawen Yu E, et al
    Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers.
    J Infect Dis. 2021;224:70-80.
    >> Share

  199. PETRIE JG, Bazzi LA, McDermott AB, Follmann D, et al
    Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses.
    J Infect Dis. 2021;224:49-59.
    >> Share

  200. KANG CK, Kim M, Lee S, Kim G, et al
    Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    J Infect Dis. 2021;224:39-48.
    >> Share

  201. DEE K, Goldfarb DM, Haney J, Amat JAR, et al
    Human Rhinovirus Infection Blocks Severe Acute Respiratory Syndrome Coronavirus 2 Replication Within the Respiratory Epithelium: Implications for COVID-19 Epidemiology.
    J Infect Dis. 2021;224:31-38.
    >> Share

  202. KRAAY ANM, Han P, Kambhampati AK, Wikswo ME, et al
    Impact of Nonpharmaceutical Interventions for Severe Acute Respiratory Syndrome Coronavirus 2 on Norovirus Outbreaks: An Analysis of Outbreaks Reported By 9 US States.
    J Infect Dis. 2021;224:9-13.
    >> Share

  203. DILLNER J, Elfstrom KM, Blomqvist J, Engstrand L, et al
    High Amounts of SARS-CoV-2 Precede Sickness Among Asymptomatic Health Care Workers.
    J Infect Dis. 2021;224:14-20.
    >> Share

  204. GIACOMELLI CAO R, Christian L, Xu Z, Jaramillo L, et al
    Early changes in interferon gene expression and antibody responses following influenza vaccination in pregnant women.
    J Infect Dis. 2021 Jul 1. pii: 6312681. doi: 10.1093.
    >> Share

    June 2021
  205. SCHWARZ TF, Johnson C, Grigat C, Apter D, et al
    Three dose levels of a maternal respiratory syncytial virus vaccine candidate are well tolerated and immunogenic in a randomized trial in non-pregnant women.
    J Infect Dis. 2021 Jun 19. pii: 6306104. doi: 10.1093.
    >> Share

  206. MA Y, Liu F, Lin T, Chen L, et al
    Large-scale identification of T cell epitopes derived from SARS-CoV-2 for the development of peptide vaccines against COVID-19.
    J Infect Dis. 2021 Jun 18. pii: 6305142. doi: 10.1093.
    >> Share

  207. BRAUNSTEIN SL, Slutsker JS, Lazar R, Shah D, et al
    Epidemiology of reported HIV and other sexually transmitted infections during the COVID-19 pandemic, New York City.
    J Infect Dis. 2021 Jun 16. pii: 6301136. doi: 10.1093.
    >> Share

  208. HAAGMANS BL, Noack D, Okba NMA, Li W, et al
    SARS-CoV-2 Neutralizing Human Antibodies Protect Against Lower Respiratory Tract Disease in a Hamster Model.
    J Infect Dis. 2021;223:2020-2028.
    >> Share

  209. HAWLEY HB, Chang JC
    Complement-Induced Endotheliopathy-Associated Vascular Microthrombosis in Coronavirus Disease 2019.
    J Infect Dis. 2021;223:2198-2199.
    >> Share

  210. DEMONBREUN AR, Sancilio A, Velez ME, Ryan DT, et al
    COVID-19 mRNA vaccination generates greater IgG levels in women compared to men.
    J Infect Dis. 2021 Jun 12. pii: 6297423. doi: 10.1093.
    >> Share

  211. RAMOS DA SILVA S, Ju E, Meng W, Paniz Mondolfi AE, et al
    Broad Severe Acute Respiratory Syndrome Coronavirus 2 Cell Tropism and Immunopathology in Lung Tissues From Fatal Coronavirus Disease 2019.
    J Infect Dis. 2021;223:1842-1854.
    >> Share

  212. ROSENBERG ES, Tesoriero JM
    A Tale of Many New York Cities.
    J Infect Dis. 2021 Jun 4. pii: 6291934. doi: 10.1093.
    >> Share

  213. RINGLANDER J, Nilsson S, Westin J, Lindh M, et al
    Low Incidence of Reinfection With Endemic Coronaviruses Diagnosed by Real-Time PCR.
    J Infect Dis. 2021;223:2013-2014.
    >> Share

    May 2021
  214. SCHNIERLE BS
    Reply to Ringlander et al.
    J Infect Dis. 2021;223:1833.
    >> Share

  215. RINGLANDER J, Martner A, Nilsson S, Westin J, et al
    Incidence and Severity of Covid-19 in Patients with and without Previously Verified Infections with Common Cold Coronaviruses.
    J Infect Dis. 2021;223:1831-1832.
    >> Share

  216. LU L, Koh CT, Lim YH, Sng A, et al
    Role of Asymptomatic Children in Community Severe Acute Respiratory Syndrome Coronavirus 2 Transmission.
    J Infect Dis. 2021;223:1834-1836.
    >> Share

  217. HAYMOND A, Damluji AA, Narayanan A, Mueller C, et al
    Durability of Viral Neutralization in Asymptomatic Coronavirus Disease 2019 for at Least 60 Days.
    J Infect Dis. 2021;223:1677-1680.
    >> Share

  218. ACOSTA-AMPUDIA Y, Rojas M, Monsalve DM, Rodriguez Y, et al
    Comment on: Nature and Dimensions of the Systemic Hyper-inflammation and Its Attenuation by Convalescent Plasma in Severe COVID-19.
    J Infect Dis. 2021;223:1833-1834.
    >> Share

  219. PEREIRA C, Harris BHL, Di Giovannantonio M, Rosadas C, et al
    The Association Between Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Post-COVID-19 Syndrome in Healthcare Workers.
    J Infect Dis. 2021;223:1671-1676.
    >> Share

  220. LEMIEUX JE, Li JZ
    Uncovering Ways That Emerging Severe Acute Respiratory Syndrome Coronavirus 2 Lineages May Increase Transmissibility.
    J Infect Dis. 2021;223:1663-1665.
    >> Share

  221. KIDD M, Richter A, Best A, Cumley N, et al
    S-Variant SARS-CoV-2 Lineage B1.1.7 Is Associated With Significantly Higher Viral Load in Samples Tested by TaqPath Polymerase Chain Reaction.
    J Infect Dis. 2021;223:1666-1670.
    >> Share

  222. DAWOOD FS, Varner M, Munoz F, Stockwell MS, et al
    Respiratory Viral Infections and Infection Prevention Practices among Women with Acute Respiratory Illness during Delivery Hospitalizations during the 2019-2020 Influenza Season.
    J Infect Dis. 2021 May 25. pii: 6284115. doi: 10.1093.
    >> Share

  223. XIE C, Su W, Sia SF, Choy KT, et al
    A(H1N1)pdm09 influenza viruses replicating in ferret upper or lower respiratory tract differed in onward transmission potential by air.
    J Infect Dis. 2021 May 24. pii: 6283765. doi: 10.1093.
    >> Share

  224. FELDSTEIN LR, Ferdinands JM, Self WH, Randolph AG, et al
    Modeling the impacts of clinical influenza testing on influenza vaccine effectiveness estimates.
    J Infect Dis. 2021 May 20. pii: 6278475. doi: 10.1093.
    >> Share

  225. SYNOLAKI E, Papadopoulos V, Divolis G, Tsahouridou O, et al
    The Activin/Follistatin Axis Is Severely Deregulated in COVID-19 and Independently Associated With In-Hospital Mortality.
    J Infect Dis. 2021;223:1544-1554.
    >> Share

  226. AVADHANULA V, Nicholson EG, Ferlic-Stark L, Piedra FA, et al
    Viral Load of Severe Acute Respiratory Syndrome Coronavirus 2 in Adults During the First and Second Wave of Coronavirus Disease 2019 Pandemic in Houston, Texas: The Potential of the Superspreader.
    J Infect Dis. 2021;223:1528-1537.
    >> Share

  227. RAMAN RS, Bhagwan Barge V, Anil Kumar D, Dandu H, et al
    A Phase II Safety and Efficacy Study on Prognosis of Moderate Pneumonia in Coronavirus Disease 2019 Patients With Regular Intravenous Immunoglobulin Therapy.
    J Infect Dis. 2021;223:1538-1543.
    >> Share

  228. TARHINI H, Recoing A, Bridier-Nahmias A, Rahi M, et al
    Long-Term Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectiousness Among Three Immunocompromised Patients: From Prolonged Viral Shedding to SARS-CoV-2 Superinfection.
    J Infect Dis. 2021;223:1522-1527.
    >> Share

  229. RICHARDS KA, Glover M, Crawford JC, Thomas PG, et al
    Circulating CD4 T Cells Elicited by Endemic Coronaviruses Display Vast Disparities in Abundance and Functional Potential Linked to Antigen Specificity and Age.
    J Infect Dis. 2021;223:1555-1563.
    >> Share

  230. CHEN J, Vitetta L
    Increased PD-L1 Expression May Be Associated With the Cytokine Storm and CD8+ T-Cell Exhaustion in Severe COVID-19.
    J Infect Dis. 2021;223:1659-1660.
    >> Share

  231. OUWENDIJK WJD, Raadsen MP, van Kampen JJA, Verdijk RM, et al
    High Levels of Neutrophil Extracellular Traps Persist in the Lower Respiratory Tract of Critically Ill Patients With Coronavirus Disease 2019.
    J Infect Dis. 2021;223:1512-1521.
    >> Share

  232. TELUGUAKULA N
    Neutrophils Set Extracellular Traps to Injure Lungs in Coronavirus Disease 2019.
    J Infect Dis. 2021;223:1503-1505.
    >> Share

  233. CHU CY, Qiu X, McCall MN, Wang L, et al
    Airway Gene Expression Correlates of Respiratory Syncytial Virus Disease Severity and Microbiome Composition in Infants.
    J Infect Dis. 2021;223:1639-1649.
    >> Share

  234. GRIER A, Gill AL, Kessler HA, Corbett A, et al
    Temporal Dysbiosis of Infant Nasal Microbiota Relative to Respiratory Syncytial Virus Infection.
    J Infect Dis. 2021;223:1650-1658.
    >> Share

  235. BIANCHI FP, Germinario CA, Migliore G, Vimercati L, et al
    BNT162b2 mRNA Covid-19 vaccine effectiveness in the prevention of SARS-CoV-2 infection: a preliminary report.
    J Infect Dis. 2021 May 19. pii: 6278131. doi: 10.1093.
    >> Share

  236. JOFFE S, Babiker A, Ellenberg SS, Fix A, et al
    Data and Safety Monitoring of COVID-19 Vaccine Clinical Trials.
    J Infect Dis. 2021 May 19. pii: 6278127. doi: 10.1093.
    >> Share

  237. COREY L
    Behind the Scenes Heroes: the COVID-19 Vaccine Data and Safety Monitoring Board.
    J Infect Dis. 2021 May 19. pii: 6278073. doi: 10.1093.
    >> Share

  238. CHA S, Henry A, Montgomery MP, Laws RL, et al
    Morbidity and Mortality among Adults Experiencing Homelessness Hospitalized with COVID-19.
    J Infect Dis. 2021 May 16. pii: 6276529. doi: 10.1093.
    >> Share

  239. BARTSCH SM, Wedlock PT, O'Shea KJ, Cox SN, et al
    Lives and Costs Saved by Expanding and Expediting COVID-19 Vaccination.
    J Infect Dis. 2021 May 6. pii: 6267841. doi: 10.1093.
    >> Share

    April 2021
  240. BAO L, Song Z, Xue J, Gao H, et al
    Susceptibility and Attenuated Transmissibility of SARS-CoV-2 in Domestic Cats.
    J Infect Dis. 2021;223:1313-1321.
    >> Share

  241. DAVIS MF, Innes GK
    The Cat's in the Bag: Despite Limited Cat-to-Cat Severe Acute Respiratory Syndrome Coronavirus 2 Transmission, One Health Surveillance Efforts Are Needed.
    J Infect Dis. 2021;223:1309-1312.
    >> Share

  242. LUZZATTO-FEGIZ P, Temprano-Coleto F, Peaudecerf FJ, Landel JR, et al
    UVB Radiation Alone May Not Explain Sunlight Inactivation of SARS-CoV-2.
    J Infect Dis. 2021;223:1500-1502.
    >> Share

  243. JANSSEN NAF, Grondman I, de Nooijer AH, Boahen CK, et al
    Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19.
    J Infect Dis. 2021;223:1322-1333.
    >> Share

  244. BAUER W, Ulke J, Galtung N, Strasser-Marsik LC, et al
    Role of Cell Adhesion Molecules for Prognosis of Disease Development of Patients With and Without COVID-19 in the Emergency Department.
    J Infect Dis. 2021;223:1497-1499.
    >> Share

  245. THIEDE JM, Gress AR, Libby SD, Ronayne CE, et al
    Immune Profiling to Determine Early Disease Trajectories Associated With Coronavirus Disease 2019 Mortality Rate: A Substudy from the ACTT-1 Trial.
    J Infect Dis. 2021;223:1339-1344.
    >> Share

  246. BOLOTIN S, Tran V, Osman S, Brown KA, et al
    SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline.
    J Infect Dis. 2021;223:1334-1338.
    >> Share

  247. KALKOWSKA DA, Pallansch MA, Cochi SL, Thompson KM, et al
    Updated characterization of poliovirus transmission in Pakistan and Afghanistan and the impacts of different outbreak response vaccine options.
    J Infect Dis. 2021 Apr 22. pii: 6246102. doi: 10.1093.
    >> Share

  248. KALA S, Meteleva K, Serghides L
    ACE2, TMPRSS2 and L-SIGN expression in placentae from HIV-positive pregnancies exposed to antiretroviral therapy-implications for SARS-CoV-2 placental infection.
    J Infect Dis. 2021 Apr 21. pii: 6242371. doi: 10.1093.
    >> Share

  249. MCCARTNEY MM, Linderholm AL, Yamaguchi MS, Falcon AK, et al
    Predicting influenza and rhinovirus infections in airway cells utilizing volatile emissions.
    J Infect Dis. 2021 Apr 15. pii: 6226913. doi: 10.1093.
    >> Share

  250. EL SAHLY HM, Atmar RL, Sendra E, Wegel A, et al
    Topical Imiquimod Does not Provide an Adjuvant Effect when Administered with Inactivated Influenza A/H5N1 Vaccine in Healthy Young Adults.
    J Infect Dis. 2021 Apr 14. pii: 6225864. doi: 10.1093.
    >> Share

  251. SATO M, Takashita E, Katayose M, Nemoto K, et al
    Detection of variants with reduced baloxavir marboxil and oseltamivir susceptibility in children with influenza A during the 2019-2020 influenza season.
    J Infect Dis. 2021 Apr 10. pii: 6219607. doi: 10.1093.
    >> Share

  252. ABBOUD H
    Encephalitis in the Setting of COVID-19 Infection.
    J Infect Dis. 2021;223:1303.
    >> Share

  253. TJAN LH, Furukawa K, Nagano T, Kiriu T, et al
    Early Differences in Cytokine Production by Severity of Coronavirus Disease 2019.
    J Infect Dis. 2021;223:1145-1149.
    >> Share

  254. RATHE JA, Hemann EA, Eggenberger J, Li Z, et al
    SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing.
    J Infect Dis. 2021;223:1120-1131.
    >> Share

  255. EISINGER RW, Lerner AM, Fauci AS
    HIV/AIDS in the Era of COVID-19: A Juxtaposition of Two Pandemics.
    J Infect Dis. 2021 Apr 7. pii: 6167835. doi: 10.1093.
    >> Share

    March 2021
  256. LAMARCA JH, de Carvalho FG, Machado FC, Lacerda-Santos R, et al
    Severe Acute Respiratory Syndrome Coronavirus 2: A Protocol for Disinfection of Toothbrushes.
    J Infect Dis. 2021;223:1113-1114.
    >> Share

  257. KLINGLER J, Weiss S, Itri V, Liu X, et al
    Role of Immunoglobulin M and A Antibodies in the Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2.
    J Infect Dis. 2021;223:957-970.
    >> Share

  258. HUGHES EC, Amat JAR, Haney J, Parr YA, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Serosurveillance in a Patient Population Reveals Differences in Virus Exposure and Antibody-Mediated Immunity According to Host Demography and Healthcare Setting.
    J Infect Dis. 2021;223:971-980.
    >> Share

  259. STRICH JR, Ramos-Benitez MJ, Randazzo D, Stein SR, et al
    Fostamatinib Inhibits Neutrophils Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic.
    J Infect Dis. 2021;223:981-984.
    >> Share

  260. IZURIETA HS, Graham DJ, Jiao Y, Hu M, et al
    Natural History of Coronavirus Disease 2019: Risk Factors for Hospitalizations and Deaths Among >26 Million US Medicare Beneficiaries.
    J Infect Dis. 2021;223:945-956.
    >> Share

  261. PETITO E, Falcinelli E, Paliani U, Cesari E, et al
    Association of Neutrophil Activation, More Than Platelet Activation, With Thrombotic Complications in Coronavirus Disease 2019.
    J Infect Dis. 2021;223:933-944.
    >> Share

  262. NICOLAS DE LAMBALLERIE C, Pizzorno A, Dubois J, Padey B, et al
    Human Respiratory Syncytial Virus-Induced Immune Signature of Infection Revealed by Transcriptome Analysis of Clinical Pediatric Nasopharyngeal Swab Samples.
    J Infect Dis. 2021;223:1052-1061.
    >> Share

  263. JORDAN E, Lawrence SJ, Meyer TPH, Schmidt D, et al
    Broad Antibody and Cellular Immune Response From a Phase 2 Clinical Trial With a Novel Multivalent Poxvirus-Based Respiratory Syncytial Virus Vaccine.
    J Infect Dis. 2021;223:1062-1072.
    >> Share

  264. LAMOTH F, Lewis RE, Walsh TJ, Kontoyiannis DP, et al
    Navigating the uncertainties of COVID-19 associated aspergillosis (CAPA): A comparison with influenza associated aspergillosis (IAPA).
    J Infect Dis. 2021 Mar 26. pii: 6189669. doi: 10.1093.
    >> Share

  265. LEWNARD JA, Bruxvoort KJ, Fischer H, Hong VX, et al
    Prevention of COVID-19 among older adults receiving pneumococcal conjugate vaccine suggests interactions between Streptococcus pneumoniae and SARS-CoV-2 in the respiratory tract.
    J Infect Dis. 2021 Mar 9. pii: 6164926. doi: 10.1093.
    >> Share

  266. MCBRIDE DS, Perofsky AC, Nolting JM, Nelson MI, et al
    Tracing the source of influenza A virus zoonoses in interconnected circuits of swine exhibitions.
    J Infect Dis. 2021 Mar 4. pii: 6158869. doi: 10.1093.
    >> Share

  267. BHATNAGAR J, Gary J, Reagan-Steiner S, Estetter LB, et al
    Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Tropism in the Lungs, Airways, and Vascular Endothelium of Patients With Fatal Coronavirus Disease 2019: An Autopsy Case Series.
    J Infect Dis. 2021;223:752-764.
    >> Share

  268. GIRARDIN RC, Dupuis AP, Payne AF, Sullivan TJ, et al
    Temporal Analysis of Serial Donations Reveals Decrease in Neutralizing Capacity and Justifies Revised Qualifying Criteria for Coronavirus Disease 2019 Convalescent Plasma.
    J Infect Dis. 2021;223:743-751.
    >> Share

  269. BLOCH EM, Crowe EP, Tobian AAR
    Coronavirus Disease 2019 Convalescent Plasma and the Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Titer.
    J Infect Dis. 2021;223:740-742.
    >> Share

  270. ZHENG J, Wang Y, Li K, Meyerholz DK, et al
    Severe Acute Respiratory Syndrome Coronavirus 2-Induced Immune Activation and Death of Monocyte-Derived Human Macrophages and Dendritic Cells.
    J Infect Dis. 2021;223:785-795.
    >> Share

  271. KLUMPP-THOMAS C, Kalish H, Hicks J, Mehalko J, et al
    Effect of D614G Spike Variant on Immunoglobulin G, M, or A Spike Seroassay Performance.
    J Infect Dis. 2021;223:802-804.
    >> Share

  272. BOWMAN ER, Cameron CMA, Avery A, Gabriel J, et al
    Levels of Soluble CD14 and Tumor Necrosis Factor Receptors 1 and 2 May Be Predictive of Death in Severe Coronavirus Disease 2019.
    J Infect Dis. 2021;223:805-810.
    >> Share

  273. RIEDER M, Wirth L, Pollmeier L, Jeserich M, et al
    Serum Protein Profiling Reveals a Specific Upregulation of the Immunomodulatory Protein Progranulin in Coronavirus Disease 2019.
    J Infect Dis. 2021;223:775-784.
    >> Share

  274. JAHRSDORFER B, Kroschel J, Ludwig C, Corman VM, et al
    Independent Side-by-Side Validation and Comparison of 4 Serological Platforms for SARS-CoV-2 Antibody Testing.
    J Infect Dis. 2021;223:796-801.
    >> Share

  275. CHATZIDIMITRIOU M, Chatzopoulou F, Gavriilaki E, Chatzivasileiou P, et al
    Repeated Negative Serological Testing in Otherwise Healthy Patients With Coronavirus Disease 2019.
    J Infect Dis. 2021;223:924-926.
    >> Share

  276. CODY MEISSNER H
    Approaching the End of the Era of Uncontrolled Respiratory Syncytial Virus Disease.
    J Infect Dis. 2021;223:737-739.
    >> Share

  277. THOMAS E, Mattila JM, Lehtinen P, Vuorinen T, et al
    Burden of Respiratory Syncytial Virus Infection During the First Year of Life.
    J Infect Dis. 2021;223:811-817.
    >> Share

  278. CHORENO-PARRA JA, Jimenez-Alvarez LA, Ramirez-Martinez G, Cruz-Lagunas A, et al
    Expression of Surfactant protein D (SP-D) distinguishes severe pandemic influenza A(H1N1) from COVID-19.
    J Infect Dis. 2021 Mar 1. pii: 6154795. doi: 10.1093.
    >> Share

    February 2021
  279. BULFONE TC, Malekinejad M, Rutherford GW, Razani N, et al
    Outdoor Transmission of SARS-CoV-2 and Other Respiratory Viruses: A Systematic Review.
    J Infect Dis. 2021;223:550-561.
    >> Share

  280. LERSY F, Benotmane I, Helms J, Collange O, et al
    Cerebrospinal Fluid Features in Patients With Coronavirus Disease 2019 and Neurological Manifestations: Correlation with Brain Magnetic Resonance Imaging Findings in 58 Patients.
    J Infect Dis. 2021;223:600-609.
    >> Share

  281. TRIEU MC, Bansal A, Madsen A, Zhou F, et al
    SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.
    J Infect Dis. 2021;223:589-599.
    >> Share

  282. SINHA P, Jafarzadeh SR, Assoumou SA, Bielick CG, et al
    The Effect of IL-6 Inhibitors on Mortality Among Hospitalized COVID-19 Patients: A Multicenter Study.
    J Infect Dis. 2021;223:581-588.
    >> Share

  283. BEDIN AS, Makinson A, Picot MC, Mennechet F, et al
    Monocyte CD169 Expression as a Biomarker in the Early Diagnosis of Coronavirus Disease 2019.
    J Infect Dis. 2021;223:562-567.
    >> Share

  284. LI A, Ling Y, Song Z, Cheng X, et al
    Correlation Between Early Plasma Interleukin 37 Responses With Low Inflammatory Cytokine Levels and Benign Clinical Outcomes in Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    J Infect Dis. 2021;223:568-580.
    >> Share

  285. DAI M, Li H, Yan N, Huang J, et al
    Long-term Survival of SARS-CoV-2 on Salmon as a Source for International Transmission.
    J Infect Dis. 2021;223:537-539.
    >> Share

  286. MOHKHEDKAR M, Venigalla SSK, Janakiraman V
    Autoantigens That May Explain Postinfection Autoimmune Manifestations in Patients With Coronavirus Disease 2019 Displaying Neurological Conditions.
    J Infect Dis. 2021;223:536-537.
    >> Share

  287. MUECKSCH F, Wise H, Batchelor B, Squires M, et al
    Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients.
    J Infect Dis. 2021;223:389-398.
    >> Share

  288. GOLDSTEIN E, Lipsitch M, Cevik M
    On the Effect of Age on the Transmission of SARS-CoV-2 in Households, Schools, and the Community.
    J Infect Dis. 2021;223:362-369.
    >> Share

  289. LIM JT, Chew LZX, Choo ELW, Dickens BSL, et al
    Increased Dengue Transmissions in Singapore Attributable to SARS-CoV-2 Social Distancing Measures.
    J Infect Dis. 2021;223:399-402.
    >> Share

  290. MAROSSY A, Rakowicz S, Bhan A, Noon S, et al
    A Study of Universal Severe Acute Respiratory Syndrome Coronavirus 2 RNA Testing Among Residents and Staff in a Large Group of Care Homes in South London.
    J Infect Dis. 2021;223:381-388.
    >> Share

  291. GALANTI M, Shaman J
    Direct Observation of Repeated Infections With Endemic Coronaviruses.
    J Infect Dis. 2021;223:409-415.
    >> Share

  292. BEHR MA, Divangahi M, Schurr E
    Lessons From Bacille Calmette-Guerin for SARS-CoV-2 Vaccine Candidates.
    J Infect Dis. 2021;223:189-191.
    >> Share

  293. HARRIS BHL, Zuhair M, Di Giovannantonio M, Rosadas C, et al
    Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Rehabilitation Facility: Evolution of the Presence of Nasopharyngeal SARS-CoV-2 and Serological Antibody Responses.
    J Infect Dis. 2021;223:192-196.
    >> Share

  294. BRANDSMA E, Verhagen HJMP, van de Laar TJW, Claas ECJ, et al
    Rapid, Sensitive, and Specific Severe Acute Respiratory Syndrome Coronavirus 2 Detection: A Multicenter Comparison Between Standard Quantitative Reverse-Transcriptase Polymerase Chain Reaction and CRISPR-Based DETECTR.
    J Infect Dis. 2021;223:206-213.
    >> Share

  295. CRAWFORD KHD, Dingens AS, Eguia R, Wolf CR, et al
    Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    J Infect Dis. 2021;223:197-205.
    >> Share

  296. DE NOOIJER AH, Grondman I, Janssen NAF, Netea MG, et al
    Complement Activation in the Disease Course of Coronavirus Disease 2019 and Its Effects on Clinical Outcomes.
    J Infect Dis. 2021;223:214-224.
    >> Share

  297. MANSBACH JM, Geller RJ, Hasegawa K, Piedra PA, et al
    Detection of Respiratory Syncytial Virus or Rhinovirus Weeks After Hospitalization for Bronchiolitis and the Risk of Recurrent Wheezing.
    J Infect Dis. 2021;223:268-277.
    >> Share

    January 2021
  298. JENNESS SM, Le Guillou A, Chandra C, Mann LM, et al
    Projected HIV and Bacterial STI Incidence Following COVID-Related Sexual Distancing and Clinical Service Interruption.
    J Infect Dis. 2021 Jan 28. pii: 6122459. doi: 10.1093.
    >> Share

  299. EATON EF, Clement ME
    Wave the Yellow Flag: Why we should prioritize routine HIV and STI care now.
    J Infect Dis. 2021 Jan 27. pii: 6121541. doi: 10.1093.
    >> Share

  300. SUNTARATTIWONG P, Mott JA, Mohanty S, Sinthuwattanawibool C, et al
    The feasibility and performance of participant-collected mid-turbinate nasal swabs for detection of influenza virus, respiratory syncytial virus, and human metapneumovirus infections among pregnant women.
    J Infect Dis. 2021 Jan 18. pii: 6103926. doi: 10.1093.
    >> Share

  301. BUI CHT, Yeung HW, Ho JCW, Leung CYH, et al
    Tropism of SARS-CoV-2, SARS-CoV and influenza virus in canine tissue explants.
    J Infect Dis. 2021 Jan 4. pii: 6062634. doi: 10.1093.
    >> Share

  302. LI L, Huang M, Shen J, Wang Y, et al
    Serum Levels of Soluble Platelet Endothelial Cell Adhesion Molecule 1 in COVID-19 Patients Are Associated With Disease Severity.
    J Infect Dis. 2021;223:178-179.
    >> Share

  303. MONCUNILL G, Mayor A, Santano R, Jimenez A, et al
    SARS-CoV-2 Seroprevalence and Antibody Kinetics Among Health Care Workers in a Spanish Hospital After 3 Months of Follow-up.
    J Infect Dis. 2021;223:62-71.
    >> Share

  304. HENSS L, Scholz T, von Rhein C, Wieters I, et al
    Analysis of Humoral Immune Responses in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    J Infect Dis. 2021;223:56-61.
    >> Share

  305. LEE WT, Girardin RC, Dupuis AP, Kulas KE, et al
    Neutralizing Antibody Responses in COVID-19 Convalescent Sera.
    J Infect Dis. 2021;223:47-55.
    >> Share

  306. SUN H, Jain A, Leone MJ, Alabsi HS, et al
    CoVA: An Acuity Score for Outpatient Screening that Predicts Coronavirus Disease 2019 Prognosis.
    J Infect Dis. 2021;223:38-46.
    >> Share

  307. BAANG JH, Smith C, Mirabelli C, Valesano AL, et al
    Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient.
    J Infect Dis. 2021;223:23-27.
    >> Share

  308. ZHU J, Wu C, Wu L
    Associations Between Genetically Predicted Protein Levels and COVID-19 Severity.
    J Infect Dis. 2021;223:19-22.
    >> Share

  309. YILMAZ A, Marklund E, Andersson M, Nilsson S, et al
    Upper Respiratory Tract Levels of Severe Acute Respiratory Syndrome Coronavirus 2 RNA and Duration of Viral RNA Shedding Do Not Differ Between Patients With Mild and Severe/Critical Coronavirus Disease 2019.
    J Infect Dis. 2021;223:15-18.
    >> Share

  310. PATI A, Padhi S, Suvankar S, Panda AK, et al
    Minor Allele of Interferon-Induced Transmembrane Protein 3 Polymorphism (rs12252) Is Covered Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Mortality: A Worldwide Epidemiological Investigation.
    J Infect Dis. 2021;223:175-178.
    >> Share

  311. KIDDE J, Sahebkar A
    From Foe to Friend in COVID-19: Renin-Angiotensin System Inhibitors.
    J Infect Dis. 2021;223:174-175.
    >> Share

  312. HICKS SM, Pohl K, Neeman T, McNamara HA, et al
    A Dual-Antigen Enzyme-Linked Immunosorbent Assay Allows the Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in a Low-Transmission Setting.
    J Infect Dis. 2021;223:10-14.
    >> Share

  313. PILOTTO A, Masciocchi S, Volonghi I, Crabbio M, et al
    Clinical Presentation and Outcomes of Severe Acute Respiratory Syndrome Coronavirus 2-Related Encephalitis: The ENCOVID Multicenter Study.
    J Infect Dis. 2021;223:28-37.
    >> Share

  314. PILAROWSKI G, Lebel P, Sunshine S, Liu J, et al
    Performance characteristics of a rapid SARS-CoV-2 antigen detection assay at a public plaza testing site in San Francisco.
    J Infect Dis. 2021 Jan 4. pii: 6061974. doi: 10.1093.
    >> Share

  315. TONG M, Zheng Q, Zhu Y
    Reply to Li et al.
    J Infect Dis. 2021;223:179-180.
    >> Share

  316. LEMPAINEN J, Korhonen LS, Kantojarvi K, Heinonen S, et al
    Associations Between IFI44L Gene Variants and Rates of Respiratory Tract Infections During Early Childhood.
    J Infect Dis. 2021;223:157-165.
    >> Share

  317. MALTEZOU HC, Raftopoulos V, Vorou R, Papadima K, et al
    Association between upper respiratory tract viral load, comorbidities, disease severity and outcome of patients with SARS-CoV-2 infection.
    J Infect Dis. 2021 Jan 3. pii: 6060070. doi: 10.1093.
    >> Share

    December 2020
  318. TENFORDE MW, Talbot HK, Trabue CH, Gaglani M, et al
    Influenza vaccine effectiveness against hospitalization in the United States, 2019-2020.
    J Infect Dis. 2020 Dec 30. pii: 6055595. doi: 10.1093.
    >> Share

  319. KUBALE J, Balmaseda A, Sanchez N, Lopez R, et al
    Pneumonia following symptomatic influenza infection among Nicaraguan children before and after introduction of the pneumococcal conjugate vaccine.
    J Infect Dis. 2020 Dec 22. pii: 6044070. doi: 10.1093.
    >> Share

  320. KIMBALL J, Zhu Y, Wyatt D, Trabue CH, et al
    Influenza Vaccine Failure Associated with Age and Immunosuppression.
    J Infect Dis. 2020 Dec 19. pii: 6041867. doi: 10.1093.
    >> Share

  321. FERDINANDS JM, Gaglani M, Ghamande S, Martin ET, et al
    Vaccine effectiveness against influenza-associated hospitalizations among adults, 2018-2019, US Hospitalized Adult Influenza Vaccine Effectiveness Network.
    J Infect Dis. 2020 Dec 18. pii: 6041424. doi: 10.1093.
    >> Share

    November 2020
  322. CLEMENS EA, Holbrook BC, Kanekiyo M, Yewdell JW, et al
    An R848 conjugated influenza virus vaccine elicits robust IgG to hemagglutinin stem in a newborn nonhuman primate model.
    J Infect Dis. 2020 Nov 27. pii: 6007684. doi: 10.1093.
    >> Share

  323. TAN TQ, Kullar R, Swartz TH, Mathew TA, et al
    Location Matters: Geographic Disparities and Impact of Coronavirus Disease 2019.
    J Infect Dis. 2020;222:1951-1954.
    >> Share

  324. SCHWAIGER J, Karbiener M, Aberham C, Farcet MR, et al
    No SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected Before the 2020 Pandemic.
    J Infect Dis. 2020;222:1960-1964.
    >> Share

  325. VITTE J, Diallo AB, Boumaza A, Lopez A, et al
    A Granulocytic Signature Identifies COVID-19 and Its Severity.
    J Infect Dis. 2020;222:1985-1996.
    >> Share

  326. BENNER SE, Patel EU, Laeyendecker O, Pekosz A, et al
    SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors.
    J Infect Dis. 2020;222:1974-1984.
    >> Share

  327. NARANBHAI V, Chang CC, Beltran WFG, Miller TE, et al
    High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts.
    J Infect Dis. 2020;222:1955-1959.
    >> Share

  328. GNIFFKE EP, Harrington WE, Dambrauskas N, Jiang Y, et al
    Plasma From Recovered COVID-19 Patients Inhibits Spike Protein Binding to ACE2 in a Microsphere-Based Inhibition Assay.
    J Infect Dis. 2020;222:1965-1973.
    >> Share

  329. SCHIEFFELIN JS
    Infectious Disease Outbreaks: The Need For an All-in Approach.
    J Infect Dis. 2020;222:1941-1942.
    >> Share

  330. FALASCA L, Nardacci R, Colombo D, Lalle E, et al
    Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities.
    J Infect Dis. 2020;222:1807-1815.
    >> Share

  331. BINDER RA, Alarja NA, Robie ER, Kochek KE, et al
    Environmental and Aerosolized Severe Acute Respiratory Syndrome Coronavirus 2 Among Hospitalized Coronavirus Disease 2019 Patients.
    J Infect Dis. 2020;222:1798-1806.
    >> Share

  332. STERLING RK, Oakes T, Gal TS, Stevens MP, et al
    The Fibrosis-4 Index Is Associated With Need for Mechanical Ventilation and 30-Day Mortality in Patients Admitted With Coronavirus Disease 2019.
    J Infect Dis. 2020;222:1794-1797.
    >> Share

  333. GUERVILLY C, Burtey S, Sabatier F, Cauchois R, et al
    Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19.
    J Infect Dis. 2020;222:1789-1793.
    >> Share

  334. ZOU Y, Wang BR, Sun L, Xu S, et al
    The Issue of Recurrently Positive Patients Who Recovered From COVID-19 According to the Current Discharge Criteria: Investigation of Patients from Multiple Medical Institutions in Wuhan, China.
    J Infect Dis. 2020;222:1784-1788.
    >> Share

  335. FJELLTVEIT EB, Cox RJ, Ostensjo J, Blomberg B, et al
    Point-of-care influenza testing impacts clinical decision, patient flow and length of stay in hospitalized adults.
    J Infect Dis. 2020 Nov 5. pii: 5957176. doi: 10.1093.
    >> Share

  336. MARTIN ET, Cheng C, Petrie JG, Alyanak E, et al
    Low influenza vaccine effectiveness against A(H3N2) associated hospitalizations in the 2016-2017 and 2017-2018 seasons of the Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).
    J Infect Dis. 2020 Nov 3. pii: 5952469. doi: 10.1093.
    >> Share

  337. SALMON DA, Dudley MZ, Carleton BC
    Guillain-Barre Syndrome Following Influenza Vaccines Affords Opportunity to Improve Vaccine Confidence.
    J Infect Dis. 2020 Nov 2. pii: 5952166. doi: 10.1093.
    >> Share

  338. PEREZ-VILAR S, Hu M, Weintraub E, Arya D, et al
    Guillain-Barre Syndrome After High-Dose Influenza Vaccine Administration in the United States, 2018-2019 Season.
    J Infect Dis. 2020 Nov 2. pii: 5952165. doi: 10.1093.
    >> Share

    October 2020
  339. WANG W, Chen X, Wang Y, Lai S, et al
    Serological evidence of human infection with avian influenza A(H7N9) virus: a systematic review and meta-analysis.
    J Infect Dis. 2020 Oct 29. pii: 5943032. doi: 10.1093.
    >> Share

  340. HINOJOSA M, Shepard SS, Chung JR, King JP, et al
    Impact of Immune Priming, Vaccination and Infection on Influenza A(H3N2) Antibody Landscapes in Children.
    J Infect Dis. 2020 Oct 22. pii: 5934948. doi: 10.1093.
    >> Share

  341. MANCINI F, Barbanti F, Scaturro M, Fontana S, et al
    Multiplex rt-Real Time PCR assays for diagnostic testing of SARS-CoV-2 and seasonal influenza viruses. A challenge of the phase 3 pandemic setting.
    J Infect Dis. 2020 Oct 20. pii: 5932324. doi: 10.1093.
    >> Share

  342. SHANNON I, White CL, Yang H, Nayak JL, et al
    Differences in influenza-specific CD4 T cell mediated immunity following acute infection versus inactivated vaccination in children.
    J Infect Dis. 2020 Oct 19. pii: 5930368. doi: 10.1093.
    >> Share

  343. WEISS S, Klingler J, Hioe C, Amanat F, et al
    A High-Throughput Assay for Circulating Antibodies Directed Against the S Protein of Severe Acute Respiratory Syndrome Coronavirus 2.
    J Infect Dis. 2020;222:1629-1634.
    >> Share

  344. SAUCEDA JA, Neilands TB, Lightfoot M, Saberi P, et al
    Findings From a Probability-Based Survey of United States Households About Prevention Measures Based on Race, Ethnicity, and Age in Response to Severe Acute Respiratory Syndrome Coronavirus 2.
    J Infect Dis. 2020;222:1607-1611.
    >> Share

  345. SUGANO N, Ando W, Fukushima W
    Cluster of Severe Acute Respiratory Syndrome Coronavirus 2 Infections Linked to Music Clubs in Osaka, Japan.
    J Infect Dis. 2020;222:1635-1640.
    >> Share

  346. BRADFUTE SB, Hurwitz I, Yingling AV, Ye C, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibody Titers in Convalescent Plasma and Recipients in New Mexico: An Open Treatment Study in Patients With Coronavirus Disease 2019.
    J Infect Dis. 2020;222:1620-1628.
    >> Share

  347. KOO BS, Oh H, Kim G, Hwang EH, et al
    Transient Lymphopenia and Interstitial Pneumonia With Endotheliitis in SARS-CoV-2-Infected Macaques.
    J Infect Dis. 2020;222:1596-1600.
    >> Share

  348. LURIE MN, Silva J, Yorlets RR, Tao J, et al
    Coronavirus Disease 2019 Epidemic Doubling Time in the United States Before and During Stay-at-Home Restrictions.
    J Infect Dis. 2020;222:1601-1606.
    >> Share

  349. LAI CKC, Chen Z, Lui G, Ling L, et al
    Prospective Study Comparing Deep Throat Saliva With Other Respiratory Tract Specimens in the Diagnosis of Novel Coronavirus Disease 2019.
    J Infect Dis. 2020;222:1612-1619.
    >> Share

  350. SHI T, Arnott A, Semogas I, Falsey AR, et al
    The Etiological Role of Common Respiratory Viruses in Acute Respiratory Infections in Older Adults: A Systematic Review and Meta-analysis.
    J Infect Dis. 2020;222.
    >> Share

  351. MILLER M
    Establishing the Value and Strategies for Respiratory Syncytial Virus (RSV) Control: The European RSV Consortium (RESCEU).
    J Infect Dis. 2020;222.
    >> Share

  352. REEVES RM, van Wijhe M, Tong S, Lehtonen T, et al
    Respiratory Syncytial Virus-Associated Hospital Admissions in Children Younger Than 5 Years in 7 European Countries Using Routinely Collected Datasets.
    J Infect Dis. 2020;222.
    >> Share

  353. LI Y, Campbell H, Nair H
    Unveiling the Risk Period for Death After Respiratory Syncytial Virus Illness in Young Children Using a Self-Controlled Case Series Design.
    J Infect Dis. 2020;222.
    >> Share

  354. WILDENBEEST JG, Zuurbier RP, Korsten K, van Houten MA, et al
    Respiratory Syncytial Virus Consortium in Europe (RESCEU) Birth Cohort Study: Defining the Burden of Infant Respiratory Syncytial Virus Disease in Europe.
    J Infect Dis. 2020;222.
    >> Share

  355. JEFFERIES K, Drysdale SB, Robinson H, Clutterbuck EA, et al
    Presumed Risk Factors and Biomarkers for Severe Respiratory Syncytial Virus Disease and Related Sequelae: Protocol for an Observational Multicenter, Case-Control Study From the Respiratory Syncytial Virus Consortium in Europe (RESCEU).
    J Infect Dis. 2020;222.
    >> Share

  356. CHUNG A, Reeves RM, Nair H, Campbell H, et al
    Hospital Admission Trends for Bronchiolitis in Scotland, 2001-2016: A National Retrospective Observational Study.
    J Infect Dis. 2020;222.
    >> Share

  357. ONER D, Drysdale SB, McPherson C, Lin GL, et al
    Biomarkers for Disease Severity in Children Infected With Respiratory Syncytial Virus: A Systematic Literature Review.
    J Infect Dis. 2020;222.
    >> Share

  358. LIN GL, Golubchik T, Drysdale S, O'Connor D, et al
    Simultaneous Viral Whole-Genome Sequencing and Differential Expression Profiling in Respiratory Syncytial Virus Infection of Infants.
    J Infect Dis. 2020;222.
    >> Share

  359. ZUURBIER RP, Bont LJ, Langedijk AC, Hamer M, et al
    Low Sensitivity of BinaxNOW RSV in Infants.
    J Infect Dis. 2020;222.
    >> Share

  360. WISEMAN DJ, Thwaites RS, Drysdale SB, Janet S, et al
    Immunological and Inflammatory Biomarkers of Susceptibility and Severity in Adult Respiratory Syncytial Virus Infections.
    J Infect Dis. 2020;222.
    >> Share

  361. ZHANG S, Akmar LZ, Bailey F, Rath BA, et al
    Cost of Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection Management in Young Children at the Regional and Global Level: A Systematic Review and Meta-Analysis.
    J Infect Dis. 2020;222.
    >> Share

  362. CHAW PS, Hua L, Cunningham S, Campbell H, et al
    Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infections in Children With Bronchopulmonary Dysplasia: Systematic Review and Meta-Analysis.
    J Infect Dis. 2020;222.
    >> Share

  363. CHAW PS, Wong SWL, Cunningham S, Campbell H, et al
    Acute Lower Respiratory Infections Associated With Respiratory Syncytial Virus in Children With Underlying Congenital Heart Disease: Systematic Review and Meta-analysis.
    J Infect Dis. 2020;222.
    >> Share

  364. SHI T, Ooi Y, Zaw EM, Utjesanovic N, et al
    Association Between Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection in Early Life and Recurrent Wheeze and Asthma in Later Childhood.
    J Infect Dis. 2020;222.
    >> Share

  365. SHI T, Denouel A, Tietjen AK, Campbell I, et al
    Global Disease Burden Estimates of Respiratory Syncytial Virus-Associated Acute Respiratory Infection in Older Adults in 2015: A Systematic Review and Meta-Analysis.
    J Infect Dis. 2020;222.
    >> Share

  366. LI D, Wolk DM, Cantor MN
    Comparing Clinical Characteristics of Influenza and Common Coronavirus Infections using Electronic Health Records.
    J Infect Dis. 2020 Oct 3. pii: 5917765. doi: 10.1093.
    >> Share

  367. RABELO-DA-PONTE FD, Silvello D, Scherer JN, Ayala AR, et al
    Convalescent Plasma Therapy in Patients With Severe or Life-Threatening COVID-19: A Metadata Analysis.
    J Infect Dis. 2020;222:1575-1578.
    >> Share

  368. DEN HARTOG G, Schepp RM, Kuijer M, GeurtsvanKessel C, et al
    SARS-CoV-2-Specific Antibody Detection for Seroepidemiology: A Multiplex Analysis Approach Accounting for Accurate Seroprevalence.
    J Infect Dis. 2020;222:1452-1461.
    >> Share

  369. SCHIAFFINO MT, Di Natale M, Garcia-Martinez E, Navarro J, et al
    Immunoserologic Detection and Diagnostic Relevance of Cross-Reactive Autoantibodies in Coronavirus Disease 2019 Patients.
    J Infect Dis. 2020;222:1439-1443.
    >> Share

  370. WANG W, Liu X, Wu S, Chen S, et al
    Definition and Risks of Cytokine Release Syndrome in 11 Critically Ill COVID-19 Patients With Pneumonia: Analysis of Disease Characteristics.
    J Infect Dis. 2020;222:1444-1451.
    >> Share

  371. ZENG QL, Yu ZJ, Ji F
    Reply to Rabelo-da-Ponte et al.
    J Infect Dis. 2020;222:1578.
    >> Share

  372. HAYDEN FG, Whitley RJ
    Respiratory Syncytial Virus Antivirals: Problems and Progress.
    J Infect Dis. 2020;222:1417-1421.
    >> Share

  373. STRAY K, Perron M, Porter DP, Anderson F, et al
    Drug Resistance Assessment Following Administration of Respiratory Syncytial Virus (RSV) Fusion Inhibitor Presatovir to Participants Experimentally Infected With RSV.
    J Infect Dis. 2020;222:1468-1477.
    >> Share

    September 2020
  374. PENKERT RR, Smith AP, Hrincius ER, McCullers JA, et al
    Vitamin A deficiency dysregulates immune responses toward influenza virus and increases mortality after bacterial coinfections.
    J Infect Dis. 2020 Sep 22. pii: 5909831. doi: 10.1093.
    >> Share

  375. ZHAO T
    Interferon-Induced Transmembrane Protein 3 Related to Coronavirus Disease 2019.
    J Infect Dis. 2020;222:1413.
    >> Share

  376. LI JZ, Yu XG
    Overcoming Challenges in Coronavirus Disease 19 Translational Research.
    J Infect Dis. 2020;222:1254-1255.
    >> Share

  377. LIU X, Tang J, Xie R, Li W, et al
    Clinical and Epidemiological Features of 46 Children <1 Year Old With Coronavirus Disease 2019 in Wuhan, China: A Descriptive Study.
    J Infect Dis. 2020;222:1293-1297.
    >> Share

  378. BOND K, Nicholson S, Lim SM, Karapanagiotidis T, et al
    Evaluation of Serological Tests for SARS-CoV-2: Implications for Serology Testing in a Low-Prevalence Setting.
    J Infect Dis. 2020;222:1280-1288.
    >> Share

  379. LEUZINGER K, Roloff T, Gosert R, Sogaard K, et al
    Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 Emergence Amidst Community-Acquired Respiratory Viruses.
    J Infect Dis. 2020;222:1270-1279.
    >> Share

  380. MEISTER TL, Bruggemann Y, Todt D, Conzelmann C, et al
    Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2.
    J Infect Dis. 2020;222:1289-1292.
    >> Share

  381. RIJKERS G, Murk JL, Wintermans B, van Looy B, et al
    Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infections.
    J Infect Dis. 2020;222:1265-1269.
    >> Share

  382. LAM KW, Chow KW, Vo J, Hou W, et al
    Continued In-Hospital Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use in Hypertensive COVID-19 Patients Is Associated With Positive Clinical Outcome.
    J Infect Dis. 2020;222:1256-1264.
    >> Share

  383. FALSEY AR, Walsh EE
    Respiratory Syncytial Virus: An Old Foe in a New Era.
    J Infect Dis. 2020;222:1245-1246.
    >> Share

  384. TSENG HF, Sy LS, Ackerson B, Solano Z, et al
    Severe Morbidity and Short- and Mid- to Long-term Mortality in Older Adults Hospitalized with Respiratory Syncytial Virus Infection.
    J Infect Dis. 2020;222:1298-1310.
    >> Share

  385. FILL MA
    Multistate Outbreak of Seoul Virus: Implications for the One Health Movement and Pandemic Preparedness.
    J Infect Dis. 2020;222:1247-1249.
    >> Share

  386. LEI H, Xu M, Wang X, Xie Y, et al
    Non-pharmaceutical interventions used to control COVID-19 reduced seasonal influenza transmission in China.
    J Infect Dis. 2020 Sep 8. pii: 5902938. doi: 10.1093.
    >> Share

  387. HADLER JL
    Will SARS-CoV-2 prevention efforts affect the coming influenza season in the United States and northern hemisphere?
    J Infect Dis. 2020 Sep 7. pii: 5902575. doi: 10.1093.
    >> Share

  388. ZIMMERMAN RK, South-Paul JE, Poland GA
    Rationing of civilian COVID-19 vaccines while supplies are limited.
    J Infect Dis. 2020 Sep 7. pii: 5902567. doi: 10.1093.
    >> Share

  389. NALIN D
    Immunosenescence and SARS-CoV-2 Vaccine Development.
    J Infect Dis. 2020 Sep 5. pii: 5901694. doi: 10.1093.
    >> Share

  390. LI Y, Wang X, Nair H
    Global Seasonality of Human Seasonal Coronaviruses: A Clue for Postpandemic Circulating Season of Severe Acute Respiratory Syndrome Coronavirus 2?
    J Infect Dis. 2020;222:1090-1097.
    >> Share

  391. SHOOK-SA BE, Boyce RM, Aiello AE
    Estimation Without Representation: Early Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Studies and the Path Forward.
    J Infect Dis. 2020;222:1086-1089.
    >> Share

  392. HELLEBERG M, Niemann CU, Moestrup KS, Kirk O, et al
    Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy.
    J Infect Dis. 2020;222:1103-1107.
    >> Share

  393. YAMAGISHI T, Ohnishi M, Matsunaga N, Kakimoto K, et al
    Environmental Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 During a COVID-19 Outbreak on the Diamond Princess Cruise Ship.
    J Infect Dis. 2020;222:1098-1102.
    >> Share

  394. SIEDNER MJ, Gandhi RT, Kim AY
    Desperate Times Call for Temperate Measures: Practicing Infectious Diseases During a Novel Pandemic.
    J Infect Dis. 2020;222:1084-1085.
    >> Share

  395. OFMAN G, Pradarelli B, Caballero MT, Bianchi A, et al
    Respiratory Failure and Death in Vulnerable Premature Children With Lower Respiratory Tract Illness.
    J Infect Dis. 2020;222:1129-1137.
    >> Share

    August 2020
  396. TAKAHASHI S, Greenhouse B, Rodriguez-Barraquer I
    Are SARS-CoV-2 seroprevalence estimates biased?
    J Infect Dis. 2020 Aug 28. pii: 5898481. doi: 10.1093.
    >> Share

  397. SADOFF J, De Paepe E, Haazen W, Omoruyi E, et al
    Safety and Immunogenicity of the Ad26.RSV.preF Investigational Vaccine Coadministered With an Influenza Vaccine in Older Adults.
    J Infect Dis. 2020 Aug 26. pii: 5897745. doi: 10.1093.
    >> Share

  398. HASFORD J
    Large Simple Double-Blind Randomized Trials for the Rapid Assessment of the Effectiveness of COVID-19 Vaccines.
    J Infect Dis. 2020 Aug 26. pii: 5897422. doi: 10.1093.
    >> Share

  399. VAN BOVEN M, Teirlinck AC, Meijer A, Hooiveld M, et al
    Estimating Transmission Parameters for Respiratory Syncytial Virus and Predicting the Impact of Maternal and Pediatric Vaccination.
    J Infect Dis. 2020 Aug 21. pii: 5895295. doi: 10.1093.
    >> Share

  400. SHI D, Wu W, Wang Q, Xu K, et al
    Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: a Single-Center 28-Day Study.
    J Infect Dis. 2020;222:910-918.
    >> Share

  401. KULLAR R, Marcelin JR, Swartz TH, Piggott DA, et al
    Racial Disparity of Coronavirus Disease 2019 in African American Communities.
    J Infect Dis. 2020;222:890-893.
    >> Share

  402. PILCHER CD, Westreich D, Hudgens MG
    Group Testing for Severe Acute Respiratory Syndrome- Coronavirus 2 to Enable Rapid Scale-up of Testing and Real-Time Surveillance of Incidence.
    J Infect Dis. 2020;222:903-909.
    >> Share

  403. TONG M, Jiang Y, Xia D, Xiong Y, et al
    Elevated Expression of Serum Endothelial Cell Adhesion Molecules in COVID-19 Patients.
    J Infect Dis. 2020;222:894-898.
    >> Share

  404. HALSTEAD SB, Katzelnick L
    COVID 19 Vaccines: Should we fear ADE?
    J Infect Dis. 2020 Aug 12. pii: 5891764. doi: 10.1093.
    >> Share

  405. PANG Y, Wang Q, Lv M, Yu M, et al
    Influenza vaccination protects against hospitalization outcomes among older patients with cardiovascular or respiratory diseases.
    J Infect Dis. 2020 Aug 11. pii: 5890841. doi: 10.1093.
    >> Share

  406. GILCA R, Carazo S, Amini R, Charest H, et al
    Common human coronaviruses seem at least as severe as influenza in patients hospitalized with acute respiratory infection: results from 8-year hospital-based surveillance in Quebec, Canada.
    J Infect Dis. 2020 Aug 6. pii: 5882014. doi: 10.1093.
    >> Share

  407. BALTRUSAITIS K, Reed C, Sewalk K, Brownstein JS, et al
    Health-care seeking behavior for respiratory illness among Flu Near You participants in the United States during the 2015-16 through 2018-19 influenza season.
    J Infect Dis. 2020 Aug 6. pii: 5881614. doi: 10.1093.
    >> Share

  408. KANZAWA M, Spindler H, Anglemyer A, Rutherford GW, et al
    Will Coronavirus Disease 2019 Become Seasonal?
    J Infect Dis. 2020;222:719-721.
    >> Share

  409. VOO TC, Clapham H, Tam CC
    Ethical Implementation of Immunity Passports During the COVID-19 Pandemic.
    J Infect Dis. 2020;222:715-718.
    >> Share

  410. CHI Y, Ge Y, Wu B, Zhang W, et al
    Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China.
    J Infect Dis. 2020;222:746-754.
    >> Share

  411. IBANEZ-SAMANIEGO L, Bighelli F, Uson C, Caravaca C, et al
    Elevation of Liver Fibrosis Index FIB-4 Is Associated With Poor Clinical Outcomes in Patients With COVID-19.
    J Infect Dis. 2020;222:726-733.
    >> Share

  412. YANG D, Chu H, Hou Y, Chai Y, et al
    Attenuated Interferon and Proinflammatory Response in SARS-CoV-2-Infected Human Dendritic Cells Is Associated With Viral Antagonism of STAT1 Phosphorylation.
    J Infect Dis. 2020;222:734-745.
    >> Share

  413. CLEMENTI N, Ferrarese R, Criscuolo E, Diotti RA, et al
    Interferon-beta-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection.
    J Infect Dis. 2020;222:722-725.
    >> Share

  414. WONG MCS, Huang J, Teoh JYC, Wong SH, et al
    Identifying a Capability Framework That Could Mitigate the Coronavirus Disease 2019 Pandemic in a Global Health Community.
    J Infect Dis. 2020;222:880-881.
    >> Share

  415. DOBRZYNSKI DM, Ndi DN, Zhu Y, Markus T, et al
    Corrigendum to: Hospital Readmissions After Laboratory-Confirmed Influenza Hospitalization.
    J Infect Dis. 2020 Aug 1. pii: 5879633. doi: 10.1093.
    >> Share

    July 2020
  416. MACIAS GIL R, Marcelin JR, Zuniga-Blanco B, Marquez C, et al
    COVID-19 Pandemic: Disparate Health Impact on the Hispanic/Latinx Population in the United States.
    J Infect Dis. 2020 Jul 30. pii: 5878913. doi: 10.1093.
    >> Share

  417. PANDA AK, Tripathy R, Das BK
    Plasmodium falciparum infection may protect a population from SARS-CoV-2 infection.
    J Infect Dis. 2020 Jul 29. pii: 5878042. doi: 10.1093.
    >> Share

  418. LI P, Liu J, Ma Z, Bramer WM, et al
    Estimating Global Epidemiology of Low-Pathogenic Human Coronaviruses in Relation to the COVID-19 Context.
    J Infect Dis. 2020;222:695-696.
    >> Share

  419. PINTO BGG, Oliveira AER, Singh Y, Jimenez L, et al
    ACE2 Expression Is Increased in the Lungs of Patients With Comorbidities Associated With Severe COVID-19.
    J Infect Dis. 2020;222:556-563.
    >> Share

  420. SCHUIT M, Ratnesar-Shumate S, Yolitz J, Williams G, et al
    Airborne SARS-CoV-2 Is Rapidly Inactivated by Simulated Sunlight.
    J Infect Dis. 2020;222:564-571.
    >> Share

  421. BAO L, Gao H, Deng W, Lv Q, et al
    Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 via Close Contact and Respiratory Droplets Among Human Angiotensin-Converting Enzyme 2 Mice.
    J Infect Dis. 2020;222:551-555.
    >> Share

  422. NICKBAKHSH S, Ho A, Marques DFP, McMenamin J, et al
    Reply to Li et al.
    J Infect Dis. 2020;222:696-698.
    >> Share

  423. TRICOCHE AD, Wagner AL, Balmaseda A, Sanchez N, et al
    Symptoms, Infection Duration, and Hemagglutinin Inhibition Antibody Response in Influenza A Infections.
    J Infect Dis. 2020 Jul 16. pii: 5872037. doi: 10.1093.
    >> Share

  424. SCHLOM J, Donahue RN
    Do Not Minimize the Impact of Cellular Immunity in the Development of Vaccines and Therapeutics for COVID-19.
    J Infect Dis. 2020 Jul 11. pii: 5870046. doi: 10.1093.
    >> Share

  425. DAWSON L, Earl J, Livezey J
    Severe Acute Respiratory Syndrome Coronavirus 2 Human Challenge Trials: Too Risky, Too Soon.
    J Infect Dis. 2020;222:514-516.
    >> Share

  426. ZENG QL, Ji F, Zhang JY
    Response to Malkovsky.
    J Infect Dis. 2020;222:510-511.
    >> Share

  427. HAO S, Lian J, Lu Y, Jia H, et al
    Decreased B Cells on Admission Associated With Prolonged Viral RNA Shedding From the Respiratory Tract in Coronavirus Disease 2019: A Case-Control Study.
    J Infect Dis. 2020;222:367-371.
    >> Share

  428. TRAUGOTT M, Aberle SW, Aberle JH, Griebler H, et al
    Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Assays in Different Stages of Infection: Comparison of Commercial Enzyme-Linked Immunosorbent Assays and Rapid Tests.
    J Infect Dis. 2020;222:362-366.
    >> Share

  429. LARGENT EA, Lynch HF
    Paying Participants in COVID-19 Trials.
    J Infect Dis. 2020;222:356-361.
    >> Share

  430. MALKOVSKY M
    Therapeutic Plasma Exchange-Neutralizing Antibody Combination Therapy for Severe Coronavirus Disease 2019.
    J Infect Dis. 2020;222:509-510.
    >> Share

  431. DAVERIO M, Amigoni A, Cavicchiolo ME
    Testing for Novel Coronavirus Antibodies: A Necessary Adjunct.
    J Infect Dis. 2020;222:517-518.
    >> Share

    June 2020
  432. O'NEIL B, Ison MG, Hallouin-Bernard MC, Nilsson AC, et al
    A Phase 2 Study of Pimodivir (JNJ-63623872) in Combination with Oseltamivir in Elderly and NonElderly Adults Hospitalized with Influenza A Infection: OPAL study.
    J Infect Dis. 2020 Jun 30. pii: 5865447. doi: 10.1093.
    >> Share

  433. HO HE, Peluso MJ, Margus C, Matias Lopes JP, et al
    Clinical outcomes and immunologic characteristics of Covid-19 in people with HIV.
    J Infect Dis. 2020 Jun 30. pii: 5864898. doi: 10.1093.
    >> Share

  434. LI L, Li X, Guo Z, Wang Z, et al
    Influence of Storage Conditions on SARS-CoV-2 Nucleic Acid Detection in Throat Swabs.
    J Infect Dis. 2020;222:203-205.
    >> Share

  435. RATNESAR-SHUMATE S, Williams G, Green B, Krause M, et al
    Simulated Sunlight Rapidly Inactivates SARS-CoV-2 on Surfaces.
    J Infect Dis. 2020;222:214-222.
    >> Share

  436. BURBELO PD, Riedo FX, Morishima C, Rawlings S, et al
    Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019.
    J Infect Dis. 2020;222:206-213.
    >> Share

  437. KOBAYASHI KI, Kaki T, Mizuno S, Kubo K, et al
    Clinical Characteristics of Patients With Coronavirus Disease 2019 in Japan: A Single-Center Case Series.
    J Infect Dis. 2020;222:194-197.
    >> Share

  438. CAI XF, Chen J, Li Hu J, Long QX, et al
    A Peptide-Based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019.
    J Infect Dis. 2020;222:189-193.
    >> Share

  439. JIANG M, Guo Y, Luo Q, Huang Z, et al
    T-Cell Subset Counts in Peripheral Blood Can Be Used as Discriminatory Biomarkers for Diagnosis and Severity Prediction of Coronavirus Disease 2019.
    J Infect Dis. 2020;222:198-202.
    >> Share

  440. ZHANG G, Nie S, Zhang Z, Zhang Z, et al
    Longitudinal Change of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in Patients with Coronavirus Disease 2019.
    J Infect Dis. 2020;222:183-188.
    >> Share

  441. SEPPALA EM, Oikarinen S, Lehtonen JP, Neupane S, et al
    Association of Picornavirus Infections With Acute Otitis Media in a Prospective Birth Cohort Study.
    J Infect Dis. 2020;222:324-332.
    >> Share

  442. THIELEN BK, Bye E, Wang X, Maroushek S, et al
    Summer Outbreak of Severe RSV-B Disease, Minnesota, 2017 Associated with Emergence of a Genetically Distinct Viral Lineage.
    J Infect Dis. 2020;222:288-297.
    >> Share

  443. UUSITUPA E, Waris M, Heikkinen T
    Association of Viral Load With Disease Severity in Outpatient Children With Respiratory Syncytial Virus Infection.
    J Infect Dis. 2020;222:298-304.
    >> Share

  444. KINLOCH NN, Ritchie G, Brumme CJ, Dong W, et al
    Suboptimal biological sampling as a probable cause of false-negative COVID-19 diagnostic test results.
    J Infect Dis. 2020 Jun 28. pii: 5864227. doi: 10.1093.
    >> Share

  445. JACKSON ML, Scott E, Kuypers J, Nalla AK, et al
    Epidemiology of respiratory syncytial virus across five influenza seasons among adults and children one year of age and older - Washington State, 2011/12 - 2015/16.
    J Infect Dis. 2020 Jun 19. pii: 5859587. doi: 10.1093.
    >> Share

  446. MINTER A, Hoschler K, Jagne YJ, Sallah H, et al
    Estimation of seasonal influenza attack rates and antibody dynamics in children using cross-sectional serological data.
    J Infect Dis. 2020 Jun 18. pii: 5859586. doi: 10.1093.
    >> Share

  447. ZHANG Y, Qin L, Zhao Y, Zhang P, et al
    Interferon-Induced Transmembrane Protein 3 Genetic Variant rs12252-C Associated With Disease Severity in Coronavirus Disease 2019.
    J Infect Dis. 2020;222:34-37.
    >> Share

  448. ZENG QL, Yu ZJ, Gou JJ, Li GM, et al
    Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in Patients With Coronavirus Disease 2019.
    J Infect Dis. 2020;222:38-43.
    >> Share

  449. NIE X, Fan L, Mu G, Tan Q, et al
    Epidemiological Characteristics and Incubation Period of 7015 Confirmed Cases With Coronavirus Disease 2019 Outside Hubei Province in China.
    J Infect Dis. 2020;222:26-33.
    >> Share

  450. NICKBAKHSH S, Ho A, Marques DFP, McMenamin J, et al
    Epidemiology of Seasonal Coronaviruses: Establishing the Context for the Emergence of Coronavirus Disease 2019.
    J Infect Dis. 2020;222:17-25.
    >> Share

  451. MOORE HC, Lim FJ, Fathima P, Barnes R, et al
    Assessing the Burden of Laboratory-Confirmed Respiratory Syncytial Virus Infection in a Population Cohort of Australian Children Through Record Linkage.
    J Infect Dis. 2020;222:92-101.
    >> Share

  452. MIDULLA F, Di Mattia G, Nenna R, Scagnolari C, et al
    Novel Variants of Respiratory Syncytial Virus A ON1 Associated With Increased Clinical Severity of Bronchiolitis.
    J Infect Dis. 2020;222:102-110.
    >> Share

  453. JIANG XL, Zhang XL, Zhao XN, Li CB, et al
    Transmission Potential of Asymptomatic and Paucisymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infections: A 3-Family Cluster Study in China.
    J Infect Dis. 2020;221:1948-1952.
    >> Share

  454. PAN Y, Yu X, Du X, Li Q, et al
    Epidemiological and Clinical Characteristics of 26 Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Carriers.
    J Infect Dis. 2020;221:1940-1947.
    >> Share

  455. ALLEN J
    My Future in Medicine: How COVID-19 Is Inspiring the Next Generation of Infectious Disease Specialists.
    J Infect Dis. 2020;221:1938-1939.
    >> Share

  456. URSIN RL, Liu H, Powell HR, Westerbeck J, et al
    Differential antibody recognition of H3N2 vaccine and seasonal influenza virus strains based on age, vaccine status, and sex in the 2017-18 season.
    J Infect Dis. 2020 Jun 4. pii: 5851359. doi: 10.1093.
    >> Share

  457. SINGH JA
    The case for why Africa should host COVID-19 candidate vaccine trials.
    J Infect Dis. 2020 Jun 3. pii: 5850913. doi: 10.1093.
    >> Share

  458. HOA LNM, Sullivan SG, Mai LQ, Khvorov A, et al
    Influenza A(H1N1)pdm09 but not A(H3N2) virus infection induces durable sero-protection: results from the Ha Nam Cohort.
    J Infect Dis. 2020 Jun 2. pii: 5850322. doi: 10.1093.
    >> Share

  459. KANG CK, Kim HR, Song KH, Keam B, et al
    Cell-Mediated Immunogenicity of Influenza Vaccination in Patients with Cancer Receiving Immune Checkpoint Inhibitors.
    J Infect Dis. 2020 Jun 1. pii: 5849850. doi: 10.1093.
    >> Share

    May 2020
  460. ROBERTS NJ
    Further discussion of a likely explanation for decreased peripheral blood anti-influenza CD8+ T cell activity during severe infection.
    J Infect Dis. 2020 May 27. pii: 5847826. doi: 10.1093.
    >> Share

  461. FUKUYAMA S, Iwatsuki-Horimoto K, Kiso M, Nakajima N, et al
    Pathogenesis of influenza A(H7N9) virus in aged non-human primates.
    J Infect Dis. 2020 May 20. pii: 5841298. doi: 10.1093.
    >> Share

  462. COWLING BJ, Thompson MG, Ng TWY, Fang VJ, et al
    Comparative Reactogenicity of Enhanced Influenza Vaccines in Older Adults.
    J Infect Dis. 2020 May 14. pii: 5837136. doi: 10.1093.
    >> Share

  463. WANG F, Nie J, Wang H, Zhao Q, et al
    Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia.
    J Infect Dis. 2020;221:1762-1769.
    >> Share

  464. WANG Y, Liu Y, Liu L, Wang X, et al
    Clinical Outcomes in 55 Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China.
    J Infect Dis. 2020;221:1770-1774.
    >> Share

  465. CUI Y, Tian M, Huang D, Wang X, et al
    A 55-Day-Old Female Infant Infected With 2019 Novel Coronavirus Disease: Presenting With Pneumonia, Liver Injury, and Heart Damage.
    J Infect Dis. 2020;221:1775-1781.
    >> Share

  466. YU P, Zhu J, Zhang Z, Han Y, et al
    A Familial Cluster of Infection Associated With the 2019 Novel Coronavirus Indicating Possible Person-to-Person Transmission During the Incubation Period.
    J Infect Dis. 2020;221:1757-1761.
    >> Share

  467. COWLING BJ, Aiello AE
    Public Health Measures to Slow Community Spread of Coronavirus Disease 2019.
    J Infect Dis. 2020;221:1749-1751.
    >> Share

  468. ZHANG N, Zhu L, Zhang Y, Zhou C, et al
    Circulating rather than alveolar extracellular DNA levels predict outcomes in influenza.
    J Infect Dis. 2020 May 10. pii: 5841516. doi: 10.1093.
    >> Share

  469. BARTSCH SM, Mitgang EA, Geller G, Cox SN, et al
    What if the Influenza Vaccine Did Not Offer Such Variable Protection?
    J Infect Dis. 2020 May 9. pii: 5835317. doi: 10.1093.
    >> Share

  470. TURNER JS, Lei T, Schmitz AJ, Day A, et al
    Impaired Cellular Immune Responses During the First Week of Severe Acute Influenza Infection.
    J Infect Dis. 2020 May 5. pii: 5830762. doi: 10.1093.
    >> Share

  471. GRAEPEL KW, Kochhar S, Clayton EW, Edwards KE, et al
    Balancing Expediency and Scientific Rigor in SARS-CoV-2 Vaccine Development.
    J Infect Dis. 2020 May 4. pii: 5828933. doi: 10.1093.
    >> Share

    April 2020
  472. CIOFFI A
    COVID-19: Is Everything Appropriate to Create an Effective Vaccine?
    J Infect Dis. 2020 Apr 29. pii: 5826955. doi: 10.1093.
    >> Share

  473. WILLIAMS K, Bastian AR, Feldman RA, Omoruyi E, et al
    Phase 1 Safety and Immunogenicity Study of a Respiratory Syncytial Virus Vaccine with an Adenovirus 26 Vector Encoding Pre-Fusion F (Ad26.RSV.preF) in adults 60 years and older.
    J Infect Dis. 2020 Apr 22. pii: 5823828. doi: 10.1093.
    >> Share

  474. ACKERSON B, An J, Sy LS, Solano Z, et al
    Cost of Hospitalization Associated with Respiratory Syncytial Virus Infection Versus Influenza Infection in Hospitalized Older Adults.
    J Infect Dis. 2020 Apr 17. pii: 5821154. doi: 10.1093.
    >> Share

  475. RYU S, Ali ST, Cowling BJ, Lau EHY, et al
    Effects of school holidays on seasonal influenza in South Korea, 2014-2016.
    J Infect Dis. 2020 Apr 11. pii: 5818974. doi: 10.1093.
    >> Share

  476. MOHN KG, Brokstad KA, Islam S, Oftung F, et al
    Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children.
    J Infect Dis. 2020;221:1528-1537.
    >> Share

  477. INCE WL, Smith FB, O'Rear JJ, Thomson M, et al
    Treatment-emergent influenza virus PA substitutions independent of those at I38 associated with reduced baloxavir susceptibility and virus rebound in trials of baloxavir marboxil.
    J Infect Dis. 2020 Apr 7. pii: 5816798. doi: 10.1093.
    >> Share

  478. SIEGERS JY, Novakovic B, Hulme KD, Marshall R, et al
    A high fat diet increases influenza A virus-associated cardiovascular damage.
    J Infect Dis. 2020 Apr 4. pii: 5815741. doi: 10.1093.
    >> Share

    March 2020
  479. EYAL N, Lipsitch M, Smith PG
    Human challenge studies to accelerate coronavirus vaccine licensure.
    J Infect Dis. 2020 Mar 31. pii: 5814216. doi: 10.1093.
    >> Share

  480. SIMOES EAF, Chirikov V, Botteman M, Kwon Y, et al
    Long-term Assessment of Healthcare Utilization 5 Years After Respiratory Syncytial Virus Infection in US Infants.
    J Infect Dis. 2020;221:1256-1270.
    >> Share

  481. PIEDRA PA
    Long-Term Healthcare Costs Associated With Respiratory Syncytial Virus Infection in Children: The Domino Effect.
    J Infect Dis. 2020;221:1205-1207.
    >> Share

  482. CHIRIKOV VV, Simoes EAF, Kuznik A, Kwon Y, et al
    Economic-Burden Trajectories in Commercially Insured US Infants With Respiratory Syncytial Virus Infection.
    J Infect Dis. 2020;221:1244-1255.
    >> Share

  483. SKOWRONSKI DM, Leir S, Sabaiduc S, Chambers C, et al
    Influenza vaccine effectiveness by A(H3N2) phylogenetic sub-cluster and prior vaccination history: 2016-17 and 2017-18 epidemics in Canada.
    J Infect Dis. 2020 Mar 26. pii: 5811682. doi: 10.1093.
    >> Share

  484. DOBRZYNSKI DM, Ndi DN, Zhu Y, Markus T, et al
    Hospital Readmissions following Laboratory-confirmed Influenza Hospitalization.
    J Infect Dis. 2020 Mar 17. pii: 5808013. doi: 10.1093.
    >> Share

  485. FONG MW, Leung NHL, Xiao J, Chu DKW, et al
    Presence of influenza virus on touch-surfaces in kindergartens and primary schools.
    J Infect Dis. 2020 Mar 16. pii: 5807949. doi: 10.1093.
    >> Share

  486. ZOU P, Wang C, Zheng S, Guo F, et al
    Invasive Pulmonary Aspergillosis in Adults With Avian Influenza A (H7N9) Pneumonia in China: A Retrospective Study.
    J Infect Dis. 2020;221.
    >> Share

  487. PHILIPPON DAM, Wu P, Cowling BJ, Lau EHY, et al
    Avian influenza human infections at the human-animal interface.
    J Infect Dis. 2020 Mar 10. pii: 5802683. doi: 10.1093.
    >> Share

  488. LEES C, Godin J, McElhaney JE, McNeil SA, et al
    Frailty Hinders Recovery From Influenza and Acute Respiratory Illness in Older Adults.
    J Infect Dis. 2020 Mar 9. pii: 5799273. doi: 10.1093.
    >> Share

  489. GRAHAM JB, Swarts JL, Menachery VD, Gralinski LE, et al
    Immune Predictors of Mortality After Ribonucleic Acid Virus Infection.
    J Infect Dis. 2020;221:882-889.
    >> Share

    February 2020
  490. IZURIETA HS, Chillarige Y, Kelman J, Wei Y, et al
    Relative effectiveness of influenza vaccines among the U.S. elderly, 2018-19.
    J Infect Dis. 2020 Feb 26. pii: 5758057. doi: 10.1093.
    >> Share

  491. SATO M, Takashita E, Katayose M, Nemoto K, et al
    Detection of variants with reduced baloxavir marboxil susceptibility after treatment of children with influenza A during the 2018/2019 influenza season.
    J Infect Dis. 2020 Feb 8. pii: 5730526. doi: 10.1093.
    >> Share

  492. FUENTES S, Hahn M, Chilcote K, Chemaly RF, et al
    Antigenic Fingerprinting of Respiratory Syncytial Virus (RSV)-A-Infected Hematopoietic Cell Transplant Recipients Reveals Importance of Mucosal Anti-RSV G Antibodies in Control of RSV Infection in Humans.
    J Infect Dis. 2020;221:636-646.
    >> Share

  493. MCFARLAND EJ, Karron RA, Muresan P, Cunningham CK, et al
    Live-attenuated respiratory syncytial virus vaccine with M2-2 deletion and with SH non-coding region is highly immunogenic in children.
    J Infect Dis. 2020 Feb 1. pii: 5719572. doi: 10.1093.
    >> Share

    January 2020
  494. GUBAREVA LV, Fry AM
    Baloxavir and Treatment-Emergent Resistance: Public Health Insights and Next Steps.
    J Infect Dis. 2020;221:337-339.
    >> Share

  495. MONTO AS
    Effectiveness of the Neuraminidase Inhibitors: The Supporting Evidence Increases.
    J Infect Dis. 2020;221:340-342.
    >> Share

  496. BOONYARATANAKORNKIT J, Vivek M, Xie H, Pergam SA, et al
    Predictive Value of Respiratory Viral Detection in the Upper Respiratory Tract for Infection of the Lower Respiratory Tract With Hematopoietic Stem Cell Transplantation.
    J Infect Dis. 2020;221:379-388.
    >> Share

    December 2019
  497. DAWOOD FS, Garg S, Fink RV, Russell ML, et al
    Epidemiology and clinical outcomes of hospitalizations for acute respiratory or febrile illness and laboratory-confirmed influenza among pregnant women during six influenza seasons, 2010-2016.
    J Infect Dis. 2019 Dec 26. pii: 5687022. doi: 10.1093.
    >> Share

  498. SHI N, Huang J, Zhang X, Bao C, et al
    Corrigendum to: Interventions in Live Poultry Markets for the Control of Avian Influenza: A Systematic Review and Meta-analysis.
    J Infect Dis. 2019 Dec 20. pii: 5682401. doi: 10.1093.
    >> Share

  499. KISO M, Yamayoshi S, Murakami J, Kawaoka Y, et al
    Baloxavir marboxil treatment of nude mice infected with influenza A virus.
    J Infect Dis. 2019 Dec 14. pii: 5677533. doi: 10.1093.
    >> Share

  500. WANG Y, Fan G, Salam A, Horby P, et al
    Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection.
    J Infect Dis. 2019 Dec 11. pii: 5673088. doi: 10.1093.
    >> Share

    November 2019
  501. SCHUIT M, Gardner S, Wood S, Bower K, et al
    The Influence of Simulated Sunlight on the Inactivation of Influenza Virus in Aerosols.
    J Infect Dis. 2019 Nov 28. pii: 5645407. doi: 10.1093.
    >> Share

  502. TENG MN, Mejias A, Ramilo O, Peeples ME, et al
    Live Attenuated Vaccine with a Stabilized Mutation and Gene Deletion for Prevention of Respiratory Syncytial Virus Disease in Young Children.
    J Infect Dis. 2019 Nov 23. pii: 5638037. doi: 10.1093.
    >> Share

  503. MCFARLAND EJ, Karron RA, Muresan P, Cunningham CK, et al
    Live respiratory syncytial virus attenuated by M2-2 deletion and stabilized temperature sensitivity mutation 1030s is a promising vaccine candidate in children.
    J Infect Dis. 2019 Nov 23. pii: 5638036. doi: 10.1093.
    >> Share

  504. KEITEL WA, Atmar RL
    Corrigendum to : Influenza Vaccines After 7 Decades: Still on the Learning Curve.
    J Infect Dis. 2019 Nov 20. pii: 5634378. doi: 10.1093.
    >> Share

  505. WALKER JL, Zhao H, Dabrera G, Andrews N, et al
    Assessment of Effectiveness of Seasonal Influenza Vaccination During Pregnancy in Preventing Influenza Infection in Infants in England, 2013-2014 and 2014-2015.
    J Infect Dis. 2019 Nov 9. pii: 5618766. doi: 10.1093.
    >> Share

  506. LEE HS, Noh JY, Shin OS, Song JY, et al
    Matrix metalloproteinase-13 in atherosclerotic plaque is increased by influenza A virus infection.
    J Infect Dis. 2019 Nov 6. pii: 5613981. doi: 10.1093.
    >> Share

  507. WALKER TA, Waite B, Thompson MG, McArthur C, et al
    Risk of Severe Influenza among Adults with Chronic Medical Conditions.
    J Infect Dis. 2019 Nov 4. pii: 5611323. doi: 10.1093.
    >> Share

    October 2019
  508. COHEN C, Nunes MC
    Vaccinating Mothers to Protect Their Babies Against Influenza.
    J Infect Dis. 2019 Oct 31. pii: 5610713. doi: 10.1093.
    >> Share

  509. FLANNERY B, Kondor RJG, Chung JR, Gaglani M, et al
    Spread of antigenically drifted influenza A(H3N2) viruses and vaccine effectiveness in the United States during the 2018-2019 season.
    J Infect Dis. 2019 Oct 30. pii: 5609441. doi: 10.1093.
    >> Share

  510. ATMAR RL, Keitel WA
    Searching for Improved Flu Vaccines - The Time Is Now.
    J Infect Dis. 2019 Oct 30. pii: 5609442. doi: 10.1093.
    >> Share

  511. MARTINEZ L, Cheng W, Wang X, Ling F, et al
    A Risk Classification Model to Predict Mortality Among Laboratory-Confirmed Avian Influenza A H7N9 Patients: A Population-Based Observational Cohort Study.
    J Infect Dis. 2019 Oct 17. pii: 5589175. doi: 10.1093.
    >> Share

  512. LU Y, Chillarige Y, Izurieta HS, Wei Y, et al
    Erratum to: Effect of Age on Relative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries Aged >/=65 Years.
    J Infect Dis. 2019 Oct 17. pii: 5588808. doi: 10.1093.
    >> Share

  513. KARRON RA, Luongo C, Mateo JS, Wanionek K, et al
    Safety and Immunogenicity of the Respiratory Syncytial Virus Vaccine RSV/DeltaNS2/Delta1313/I1314L in RSV-Seronegative Children.
    J Infect Dis. 2019 Oct 12. pii: 5586371. doi: 10.1093.
    >> Share

  514. PARK YH, Chungu K, Lee SB, Woo SJ, et al
    Host-specific restriction of avian influenza virus caused by differential dynamics of ANP32 family members.
    J Infect Dis. 2019 Oct 3. pii: 5580703. doi: 10.1093.
    >> Share

    September 2019
  515. L'HUILLIER AG, Ferreira VH, Hirzel C, Natori Y, et al
    Cell-Mediated Immune Responses after Influenza Vaccination of Solid Organ Transplant Recipients: a Secondary Outcomes Analysis of a Randomized Controlled Trial.
    J Infect Dis. 2019 Sep 24. pii: 5573328. doi: 10.1093.
    >> Share

  516. GERSHON AS, Chung H, Porter J, Campitelli MA, et al
    Influenza Vaccine Effectiveness in Preventing Hospitalizations in Older Patients With Chronic Obstructive Pulmonary Disease.
    J Infect Dis. 2019 Sep 24. pii: 5573043. doi: 10.1093.
    >> Share

  517. RAMILO O, Rodriguez-Fernandez R, Peeples ME, Mejias A, et al
    Advanced Live Attenuated Vaccines for the Prevention of Respiratory Syncytial Virus Infections in Young Children.
    J Infect Dis. 2019 Sep 24. pii: 5573046. doi: 10.1093.
    >> Share

  518. CHESNOKOV A, Patel MC, Mishin VP, De La Cruz JA, et al
    Replicative fitness of seasonal influenza A viruses with decreased susceptibility to baloxavir.
    J Infect Dis. 2019 Sep 21. pii: 5572441. doi: 10.1093.
    >> Share

    August 2019
  519. SCHWARZ TF, McPhee RA, Launay O, Leroux-Roels G, et al
    Immunogenicity and safety of 3 formulations of a respiratory syncytial virus candidate vaccine in non-pregnant women: a phase II, randomized trial.
    J Infect Dis. 2019 Aug 16. pii: 5550410. doi: 10.1093.
    >> Share

  520. MUNOZ FM, Swamy GK, Hickman SP, Agrawal S, et al
    Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants.
    J Infect Dis. 2019 Aug 12. pii: 5546089. doi: 10.1093.
    >> Share

    June 2019
  521. GERN JE, Lee WM, Swenson CA, Nakagome K, et al
    Development of a Rhinovirus Inoculum Using a Reverse Genetics Approach.
    J Infect Dis. 2019;220:187-194.
    >> Share

  522. PROUD D
    Reverse Genetics and Rhinovirus-A New Approach to an Old Problem?
    J Infect Dis. 2019;220:181-183.
    >> Share

  523. POLACK FP, Stein RT, Custovic A
    The Syndrome We Agreed to Call Bronchiolitis.
    J Infect Dis. 2019;220:184-186.
    >> Share

    May 2019
  524. CILLONIZ C, Dominedo C, Magdaleno D, Ferrer M, et al
    Pure viral sepsis secondary to Community-Acquired Pneumonia in adults: risk and prognostic factors.
    J Infect Dis. 2019 May 21. pii: 5494607. doi: 10.1093.
    >> Share

  525. MANSBACH JM, Hasegawa K, Piedra PA, Avadhanula V, et al
    Haemophilus-Dominant Nasopharyngeal Microbiota Is Associated With Delayed Clearance of Respiratory Syncytial Virus in Infants Hospitalized for Bronchiolitis.
    J Infect Dis. 2019;219:1804-1808.
    >> Share

    April 2019
  526. GARCIA-MAURINO C, Moore-Clingenpeel M, Thomas J, Mertz S, et al
    Viral Load Dynamics and Clinical Disease Severity in Infants With Respiratory Syncytial Virus Infection.
    J Infect Dis. 2019;219:1207-1215.
    >> Share

  527. YU J, Peterson DR, Baran AM, Bhattacharya S, et al
    Host Gene Expression in Nose and Blood for the Diagnosis of Viral Respiratory Infection.
    J Infect Dis. 2019;219:1151-1161.
    >> Share

    March 2019
  528. KAMAU E, Onyango CO, Otieno GP, Kiyuka PK, et al
    An Intensive, Active Surveillance Reveals Continuous Invasion and High Diversity of Rhinovirus in Households.
    J Infect Dis. 2019;219:1049-1057.
    >> Share

    February 2019
  529. VAN ERP EA, Feyaerts D, Duijst M, Mulder HL, et al
    Respiratory Syncytial Virus Infects Primary Neonatal and Adult Natural Killer Cells and Affects Their Antiviral Effector Function.
    J Infect Dis. 2019;219:723-733.
    >> Share

    January 2019
  530. KANEKIYO M, Ellis D, King NP
    New Vaccine Design and Delivery Technologies.
    J Infect Dis. 2019 Jan 31. pii: 5304933. doi: 10.1093.
    >> Share

  531. ANDERSON LJ, Peret TC, Piedra PA
    RSV Strains and Disease Severity.
    J Infect Dis. 2019;219:514-516.
    >> Share

  532. MIDULLA F, Nenna R, Scagnolari C, Petrarca L, et al
    How Respiratory Syncytial Virus Genotypes Influence the Clinical Course in Infants Hospitalized for Bronchiolitis.
    J Infect Dis. 2019;219:526-534.
    >> Share

  533. CABALLERO MT, Bianchi AM, Nuno A, Ferretti AJP, et al
    Mortality Associated With Acute Respiratory Infections Among Children at Home.
    J Infect Dis. 2019;219:358-364.
    >> Share

  534. FURUSE Y, Tamaki R, Okamoto M, Saito-Obata M, et al
    Association Between Preceding Viral Respiratory Infection and Subsequent Respiratory Illnesses Among Children: A Prospective Cohort Study in the Philippines.
    J Infect Dis. 2019;219:197-205.
    >> Share

  535. MAZUR NI, Horsley NM, Englund JA, Nederend M, et al
    Breast Milk Prefusion F Immunoglobulin G as a Correlate of Protection Against Respiratory Syncytial Virus Acute Respiratory Illness.
    J Infect Dis. 2019;219:59-67.
    >> Share

    December 2018
  536. HELLFERSCEE O, Treurnicht FK, Walaza S, du Plessis M, et al
    The fraction of rhinovirus detections attributable to mild and severe respiratory illness in a high HIV-prevalence setting, South Africa, 2013-2015.
    J Infect Dis. 2018 Dec 22. pii: 5257995. doi: 10.1093.
    >> Share

    July 2018
  537. NING T, Nie J, Huang W, Li C, et al
    Antigenic Drift of H7N9 Viral Hemagglutinin.
    J Infect Dis. 2018 Jul 5. pii: 5049177. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016